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General Introduction 9
1.1 Refractive Errors
Refractive errors are the most frequent disorders of the eye1. In the ideal refractive 
state, emmetropia, an image is focused directly on the retina, resulting in the 
perception of a sharp image in a healthy visual system (Figure 1.1.1). Such eyes 
do not require glasses or contact lenses to see sharply. Most eyes, however, 
have some degree of refractive error, although correction is not always required.
 
Figure 1.1.1 The Emmetropic Eye
(Courtesy of Ophtec BV)    
In myopia (nearsightedness), the image appears focused anterior to the retina, 
producing a sharp image at near and a blurred image at distance (Figure 1.1.2). 
A concave lens (minus Diopter) is required to sharpen the image. The reverse 
is true in hypermetropia (also known as hyperopia or farsightedness), where 
the image is projected posterior to the retina, producing a blurred image at near 
and a sharper image at distance (Figure 1.1.3). A convex lens (plus Diopter) 
is required to produce a clear image. Astigmatism (cylindrical error) is the 
result of two different refractive powers between two perpendicular meridians 
(Figure 1.1.4). A cylindrical correction can correct this problem. Extreme cases 
of all these refractive errors can cause severe visual loss. Anisometropia is the 
presence of two significantly different refractive errors. In these situations, simple 
spectacle correction is not always suitable due to aniseikonia (different sized 
images) resulting from the different powers in the lenses; other options such 
as contact lenses or surgery can then be considered. When refractive errors 
and anisometropia are not corrected aptly, diminished binocular vision and/or 
amblyopia could result. 
Refractive error is not static. Newborns are normally born hypermetropic 
(approximately +2.0 D) and emmetropise quickly to plano between 4 and 6
years of age. Lack of emmetropisation can lead to hypermetropia2. 
             Chapter 110
Figure 1.1.2 The Myopic Eye
(Courtesy of Ophtec BV)    
Figure 1.1.3 The Hypermetropic Eye
(Courtesy of Ophtec BV)    
Figure 1.1.4 The Astigmatic Eye
(Courtesy of Ophtec BV)    
Myopia generally has its onset around puberty, although in pathologic myopia, 
negative refractive error is found earlier. Myopization can continue slowly until 
about the age of 30. The development of cataract in older individuals can cause 
rapid myopization, however some patients become more hypermetropic.
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Myopia is the most common form of refractive error, being most frequent in Asia3. 
It has been described as having reached epidemic proportions in South East 
Asia, where studies among schoolchildren have found a prevalence of 81% in 
Taiwan, 73% in Singapore and 62% in rural China4-6. Frequencies are lower in 
other Eastern countries, attaining 54% in Jordan, between 20 to 37% in India 
and Pakistan, 33% in Turkey and 3.4% in Iran7-12. It is less common in Europe, 
with 11.9% in Finland, 13% among Polish schoolchildren and 33% among 
the Danes13-16. Although there definitely appear to be large differences in the 
frequency of myopia around the world, population comparisons are hampered by 
the diverse criteria used to define refractive errors, the specific population groups 
being studied (such as registered schoolchildren and military recruits), different 
age groups and whether cycloplegic drops are used for the determination of 
refractive error17.
Myopia is generally divided into two categories, simple myopia (between –1.0 
and –6.0 D) and pathologic myopia (more than –6.0 D). Complications as a result 
of pathological myopia abound. Patients run a higher risk of severe visual loss 
through retinal detachment, myopic chorioretinal degeneration, cataract and 
open-angle glaucoma18-34. The chance of such complications occurring is greater 
as the severity of myopia increases, although even eyes with simple myopia are 
not completely immune.
Animal experiments have been able to induce myopia through exposure to 
flashing lights or continuous illumination, form deprivation, lid suture, or goggling 
eyes with translucent lenses or lenses with different myopic refractive errors35-50. 
Most of these models imply that a visual feedback mechanism based on blurred 
images on the retina are fundamental to increases in axial length, and hereby the 
development of myopia. However, accelerated axial length increase can also be 
observed if the optic nerve has been severed51. Thus, the cause of myopia still 
remains elusive.
Many studies have revealed the highly hereditary nature of myopia. Twin studies 
on high myopia have shown a greater concordance among monozygotic twins 
than dizygotic twins52,53. So far, 15 loci associated with myopia have been 
established (MYP 1-15) although to date, no consistent associated genes have 
been found54-68. Still, different inheritance patterns between simple myopia and 
pathologic myopia have been implicated68-72. Genetic links in myopia could 
partially explain the dissimilar distribution of refractive errors amongst different 
ethnicities. The Baltimore Eye Survey found that 28.1% of adult urban subjects 
of European descent (living in the Baltimore area) were myopic, as opposed 
to 19.4% of African Americans73. Examinations of children of different ethnic 
backgrounds living in the same area have also found similar distributions74,75.
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Still, genes are not the only factor associated with refractive error; environmental 
aspects also appear to have a part in its development76,77. The effects of 
environment become apparent when studying individuals of similar ethnic 
backgrounds living in different places. Saw et al., observed that Chinese, Malay 
and Indian children living in Singapore expressed significantly more myopia than 
their ethnic counterparts residing in Kuala Lumpur, Malaysia78. Pertinent risk 
factors for nearsightedness have been found, whereby near work is considered 
the greatest; a study examining monozygotic and dizygotic twins and their 
reading habits was able to find a significantly higher concordance in myopia 
among monozygotic twins with comparable reading habits79. Furthermore, adult-
onset myopia is most common in individuals who are involved in intensive near 
work, such as microscopists, carpet weavers and workers using visual display 
terminals80-82. Near work is thought to have perpetrated the rise of myopia in urban 
Asia, where school-age children are becoming increasingly younger, leading to 
longer periods of near work at a younger age4,73,83-91. Animal experiments have 
been able to confirm the association between near focus and myopization 
found in humans 5, 92-98. Moreover, a consistent correlation has also been found 
between both levels of education and intelligence with myopia, although both 
these factors may be associated with the greater amount near work among these 
individuals5,16,77,88,89,99-102. Urban areas display significantly more myopia than rural 
areas, although yet again, this could be confounded by higher levels of education 
(and thus near work) among urban dwellers77,86,100,103-105.
Nearsightedness is further associated with introvert personalities and a decreased 
chance of developing schizophrenia106,107. These relationships are not necessarily 
associated with the visual environment of the individual, but more with the chemical 
and genetic relationships of myopia with these traits. According to some studies, 
myopia is also significantly more common among women10,13,107-110.
The role of light exposure and the physical effects of melatonin associated with 
myopia remain contentious94,95,107,111-119. Still, outdoor activity has been shown to 
protect against myopia11,120. While one could surmise that this could be caused by 
less accommodation during sport, indoor sport activities do not appear to prevent 
nearsightedness120. 
Hypermetropia is a less common refractive error and unlike myopia, more common 
among Caucasians121. Studies have shown frequencies of 28% in Finland, 27.4% 
of Malays residing in Singapore, 27.1% in Pakistan, 16.6% in Iran, 9.9% in the 
United States and 9.8% among South Indians 3.6%1,8,12,13,100,122. A limited number 
of family studies have shown that inheritability of hypermetropia exists53,123-125. In 
individual populations, hypermetropia shows a U-shaped distribution, with higher 
incidences among prepubescent children and then again among older individuals 
without cataract13,121,126,127. 
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Hypermetropia is much more often associated with amblyopia, decreased 
stereovision and strabismus, and can hereby pose a threat to the young eye. Also, 
the smaller ocular structures associated with hypermetropia makes hypermetropic 
eyes more prone to vision threatening acute and chronic angle closure glaucoma 
among older patients128-131.
Animal experiments show a propensity towards hypermetropia among restrained 
animals and with the use of convex or hypermetropic lenses37,44-47,49,132. Similar to 
myopia, the exact physiological events leading to hypermetropia are unknown, however 
it appears to be caused by changes in axial length and corneal flattening44, 45. 
Outdoor activity induces hypermetropic tendencies, in direct contrast to the near 
work associated with myopia120. Furthermore, farsightedness is more common 
among individuals with a lower socio-economic status133,134. Surveys have 
also determined a higher frequency of hypermetropia among youngsters with 
developmental delays135-138. Also, hypermetropia is associated with extrovert 
personalities, as opposed to introvert personalities among myopes106.
Recent attempts at slowing the progression of myopia among children with 
ocular distillation of pirenzepine, a selective M1 muscarinic receptor antagonist, 
have been mildly successful. Still, pirenzepine has yet to halt myopization 
altogether139-141. Until refractive errors can be prevented effectively, we are simply 
left with the option to correct them with spectacles, contact lenses or surgery.
1.2  A Brief History of Correcting Refractive Error
1.2.1 Glasses and Contact Lenses
For centuries, people have been trying to correct ametropia. Before the invention 
of lenses, scholars would be hired to read to those who no longer could read due to 
their vision. Others would use containers filled with water to magnify their scripts. 
In 1000 AD, “reading stones” (magnifying glasses passed over reading materials) 
were used by monks to allow for studying scriptures. The first documented use 
of spectacles was either in Florence or Pisa, Italy where two convex lenses were 
used to magnify images142,143. With the advent of Gutenberg’s printing press in 
1476, demand for spectacles increased throughout Europe143,144. Initially, there 
were single handheld lenses, which were then adapted to two lenses connected 
at in the middle, held with one hand. Nearly 350 years later, Benjamin Scarlett, 
a London optician, finally designed spectacles that were suspended on both 
ears143.
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The renowned inventor, Benjamin Franklin, has been accredited with the creation 
of “double spectacles”, which have evolved into the bifocals of today142. The basis 
of efficiently grinding several lenses at once, although significantly altered, was 
originally created by John Marshall of London, England145.
The first rough blueprints of the contact lens are accredited to da Vinci, Descartes, 
de la Hire and Young146,147. Contact lenses were first implemented independently 
near the end of the nineteenth century by three different inventors146. The French 
ophthalmologist Eugėne Kalt created contact lenses from the bottom of glass 
test tubes to counterbalance the severe astigmatism in keratoconus in 1888. The 
same year, Adolf Eugen Fick, a German physiologist, described the use of afocal 
contact lenses to counteract the optical effects of corneal distortions. Months 
later, the German physician August Müller, presented his dissertation on scleral 
contact lenses with a refractive power, based on experiments to correct his own 
myopia of -14.00 D148. Due to occurrence of severe corneal edema, Müller became 
disparaged with his idea and left Ophthalmology to pursue Orthopedic Surgery. 
Otto Himmler, a renowned maker of microscopes, manufactured these first glass-
blown contact lenses for both Müller and Fick at a respective 4 and a whopping 
38 Deutschmark price tag at his factory in Berlin149. The more current corneal 
contact lenses of today were invented by Kevin Tuohy in 1948. Professor Otto 
Wichterle of Prague patented a centrifugal casting machine to produce lenses 
of hydroxyethylmethacrylate and glycol diester (hydrogel) in 1961. These lenses 
were much more comfortable than the polymethyl methacrylate (PMMA) hard 
lenses which were in use at the time. In 1972, these “soft lenses” were introduced 
to the larger public by Bausch & Lomb146. Unlike glasses, contact lenses do not 
diminish retinal size with increasing myopia nor do they reduce visual fields148. 
Furthermore, they are lightweight and virtually invisible.
Currently, contact lenses have many different ophthalmic applications, such as 
keratoconus, aniseikonia, color blindness, ocular deformity and diplopia150-164. 
More frivolous applications also exist, such as changing ones eye color with the 
notoriously troublesome colored contact lens160,162,163,165-168. Nowadays, contact 
lenses are fabricated from a variety of materials and offer comfortable long-term 
wear and excellent refractive correction for 125 million people worldwide146,169. 
Still, microbial keratitis, often associated with corneal hypoxia and poor patient 
hygiene, dry eye and the development of contact lens intolerance, allergy 
and giant papillary conjunctivitis remain drawbacks of this form of refractive 
correction146,170-175. 
1.2.2 Refractive Surgery
The idea of reducing corneal curvature to correct myopia has existed for centuries. 
The ancient Chinese apparently slept with sandbags over their eyes in order 
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to flatten their corneas. In the 19th century, Dr. J. Ball introduced small mallet 
that would flatten the cornea through the eyelid176. Luckily, today’s more refined 
innovations have taken over these rudimentary techniques.
1.2.2.1 Refractive Keratotomy
Dr. Lans, from Leiden, the Netherlands corrected astigmatism in rabbits using the 
methods of keratectomy, keratotomy and thermoplasty in 1898. In 1933, Tokyo’s 
Dr. Sato discovered that the astigmatism of his keratoconus patient decreased 
after breaks in the Descemet membrane. This led him to perform radial incisions 
in the anterior and posterior corneas of nearly 700 patients between 1951 and 
1959. The formation of bullous keratopathy due to his toying with the corneal 
endothelium eventually led him to abandon this practice176-179.
The Radial Keratotomy (RK) procedure was introduced by several Russian eye 
surgeons in the early 1970s, the most renowned being Svyatoslav Fyodorov176-178. 
The procedure creates a flattening of the central cornea by incising the epithelial 
and stromal layers of the midperipheral cornea. The six steps to the procedure 
are as follows: 1. administration of appropriate anesthesia; 2. accurate marking 
of the visual axis; 3. marking the appropriate sized optical zone; 4. measuring the 
corneal thickness; 5. accurately setting the depth of the blade so as to be as close 
to the Descemet membrane as possible; and 6. making a predetermined number 
of corneal incisions (usually eight) to adequately flatten the cornea178. Problems 
associated with RK include overcorrection and progressive hypermetropic shift, 
diurnal fluctuations, corneal perforation and a lack of stability due to different 
wound healing patterns among patients of different age, whereby younger 
patients endure more refractive regression177,180-183.
Until the mid 1990s, RK was the most common procedure to correct myopia 
in the United States, having been performed by approximately 10% of 
ophthalmologists177. Its popularity diminished with the advent of the more refined 
excimer laser techniques.
1.2.2.2 Excimer Laser Treatments
The excimer (“excited dimer”) laser uses a 193 nm argon fluoride excimer 
laser to reshape the anterior corneal stroma through a procedure known as 
photoablation179,183,184. The laser was originally used to etch silicone computer 
chips in the 1970s by IBM185. Dr. Steven Trokel and Rangaswamy Srinivasan first 
described its use on the eye in 1983 to reshape freshly enucleated cow eyes. They 
wrote that the benefit, apart from its great precision, was that there was no damage 
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to the neighboring tissue nor was there any sign of tissue disorganization186. Dr. 
Seiler from Germany, was the first to use it on a functioning human eye in 1987176. 
In 1988, John Marshall, along with Stephen J. Koons and Charles R. Munnerlyn, 
described the Photorefractive Keratectomy (PRK) procedure in rabbit eyes187. 
The Food and Drug Administration (FDA) approved its use on human eyes in the 
United States in 1995188.
Currently, there are three main forms of excimer laser treatments available: 
PRK, Laser in situ Keratomileusis (LASIK), and Laser-Assisted Sub-Epithelial 
Keratectomy (Laser Epithelial Keratomileusis or LASEK). PRK was the first to be 
performed; during this procedure, the corneal epithelium is first removed and the 
laser treatment then takes place on the stroma. Thanks to Pallikaris of Greece 
and Buratto of Italy, who combined PRK with Jose Barraquer’s invention, the 
microkeratome, LASIK was born. It was first carried out in 1989 by Pallikaris176. 
This procedure entails the making of a stromal flap of 8 – 10 mm diameter and 
100 to 180 μm thickness with a microkeratome, the laser procedure, and then 
the replacement of the flap immediately thereafter. It allows for a nearly painless 
procedure, minimal haze and faster visual rehabilitation than PRK, although 
current technology allows for similar visual results between both188-190.
LASIK can correct higher refractive errors than PRK, although flap-related 
complications, which can be quite troublesome, can occur191-195. The femtosecond 
laser is the newest innovation in LASIK, allowing for thinner, more precise flaps with 
fewer complications, with comparable visual outcomes30,188,196,197. Other serious 
complications associated with LASIK are corneal ectasia, corneal perforation, 
diffuse lamellar keratitis, interface debris and epithelial ingrowth188,195,198-200.
LASEK was independently introduced by Dimitri Azar and Massimo Camellin in 
1999. It combines both the PRK and LASIK procedures. Diluted ethanol is used to 
create an epithelial flap (like in PRK), which is replaced on the eye after ablation 
takes place (like LASIK). Postoperative pain, haze and visual rehabilitation are 
less bothersome than with PRK, but more problematic than with LASIK201. 
All excimer laser procedures can be associated with postoperative keratitis, dry 
eye and visual disturbances such as starbursts and halos188,195,202-205. Currently, 
LASEK and PRK are indicated for low to moderate myopia, whereas LASIK is 
indicated for moderate to high myopia up to -10.0 D.
1.2.2.3 Phakic Intraocular Lens Implantations and the Artisan Lens
Several different Phakic Intraocular Lens (pIOLs) are available today – from 
anterior chamber angle-supported and iris-fixated lenses to posterior chamber 
lenses.
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English ophthalmologist Dr. Harold Ridley (1906-2001) invented the first 
intraocular lens. He had observed polymethylmethacrylate (PMMA) splinters that 
would occasionally become lodged in the eyes of World War II Fighter pilots after 
returning from missions did not lead to ocular inflammation. This inspired him 
to create an intraocular lens made of PMMA which he placed in an eye after a 
cataract operation in 1949. These first “top secret” experiments were an absolute 
failure – not only did he render his first patient highly myopic (-14.0 D), the up 
to 108 mg weight of the lens was so heavy that it would often tumble into the 
vitreous cavity behind206-208. Initially, Ridley was not appreciated by his peers, 
however he eventually went on to receive numerous prestigious awards and was 
knighted by Queen Elizabeth II in 2000206.
Since Ridley’s pioneering work, many different pseudophakic lenses were created. 
Strampelli, Dannheim, Baron and then Barraquer were some of the first to design 
phakic IOLs to correct high myopia in the 1950s. These angle-fixated lenses led 
to many serious complications, such as extreme endothelial cell loss and Uveitis-
Glaucoma-Hyphema Syndrome (UGH-Syndrome), leading many of these lenses 
to be explanted208,209. Georges Baikoff finally published work on his angle-fixated 
phakic IOL in 1991, which was adapted to prevent severe endothelial cell loss. 
Still, the new lens was also unable to escape the considerable side-effects of 
iridopathy, pupil ovalization, low-grade uveitis, peripheral synechiae and sectorial 
atrophy of the iris209.
Figure 1.2.1 Prof.Dr. J. Worst 
(Courtesy of Ophtec BV)    
Prof. Dr. Jan Worst of Groningen, the Netherlands felt that the angle-fixated pIOLs 
would always be problematic due to the contact of the haptic with the tissue 
of the anterior chamber (Figure 1.2.1). After observing his compatriot Cornelius 
Binkhorst’s innovation, the “pupil fixation” lens, which stayed partially in place 
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thanks to pilocarpine to avoid lens luxation in mydriasis, he had an epiphany. He 
devised a PMMA lens that could be fixated to the iris stroma - this would deter 
the need for chronic eye drop use and would avoid the problems associated with 
angle-fixated lenses. He also believed that this prototype would not affect pupil 
dynamics208,210. After several different models, Worst finally invented the Iris-Claw 
lens, a lens which simply could be clamped onto the midperipheral iris without 
interfering with the iris’s mechanical function of pupil dilation. Variations of the 
lens were initially used in high volume to correct aphakia in Pakistan and India. 
In 1980, Professor Worst implanted an opaque version of the lens in the eye 
of a phakic patient suffering from diplopia. Years later, the eye remained un-
inflamed with a clear cornea and a clear lens208,211. This last lens provided the 
basis for the Iris-fixated phakic IOL, which was initially implanted into the eyes 
of a highly myopic (-20 D) female patient by Dr. Paul Fechner of Germany208. 
Worst and Fechner eventually went on to implant a series of these biconcave 
“Worst-Fechner” lenses with 5.0 mm optics with very reasonable refractive 
results. However endothelial cell loss was a cause for concern, leading to the 
development of a convex-concave lens to increase the distance between the lens 
and the corneal endothelium (Figures 1.2.2 and 1.2.3)212-216.
Many studies proved that the Artisan lens led to safe and efficacious results217-221. 
Multicenter studies for the Artisan lens to correct moderate to high Myopia have 
shown postoperative best corrected visual acuity (BCVA) of 20/40 (legal visual 
acuity required to drive in most countries) in at least 93.9% of the eyes, with 
postoperative uncorrected visual acuity 20/40 in at least 76.8% of eyes222-225. At 
present, the lens is available between -1.0 to -23.5 D (0.5 increments)226.
Figure 1.2.2: The Convex – Concave design of the Artisan lens, Model 206, 5.0 mm optic 
(Courtesy of Ophtec BV)    
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Figure 1.2.3: The lens is located in the anterior chamber, between the iris and the 
cornea. The crystalline lens is visible behind the iris. (Courtesy of Ophtec BV)
Studies have shown superior visual results and contrast sensitivity with the 
Artisan lens than LASIK for the correction of high myopia (greater than -9.0 
D). Also, when compared to different phakic IOL types, there is minimal to no 
cataract formation227-232. The surface of the lens has also been studied by electron 
micrograph, revealing a smooth plane with few irregularities233. Still, complaints of 
glare and haloes remain, although these can be minimized with the Artisan Model 
204 lens (with a 6.0 mm optic), available in 0.5 D increments between -1.0 and 
-15.5 D (Figure 1.2.4)214,226,234.
Figure1.2.4: Artisan lens, Model 204, 6.0 mm optic
(Courtesy of Ophtec BV)
The Artisan lens for hypermetropia was first implanted in 1992. The lens is 
available in 0.5 D increments for corrections between +1.0 and +12.0 D226. Studies 
have demonstrated safe and predictable results. Pop did a study comparing clear 
lens extraction and the Artisan hypermetropic lens and concluded that although 
visual results between the two were comparable, the Artisan hypermetropic lens 
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is more suitable for young high hypermetropes so that their accommodation may 
remain intact235. Nevertheless, pigment dispersion due to the small size of the 
eye remains a problem with this lens236.
Since the development of the toric Artisan Lens in 2001, astigmatic hypermetropic 
or myopic patients, and patients with keratoconus can also be treated with an 
intraocular lens237-239. Unlike the regular Artisan lens, the axis of enclavation is of 
particular importance with the toric Artisan lens238,240,241. Studies have proven that 
this lens is stable once implanted in the eye, which is of substantial importance, 
as postoperative movement of the lens would cause a change in the astigmatic 
correction242. Both the toric and myopia lens can be used with relatively good 
visual results in eyes undergoing or having undergone penetrating keratoplasty, 
implantation of Intacs, after radial keratotomy or in eyes with Pellucid Marginal 
Degeneration217,234,243-247.
The Artiflex lens was introduced in 2003 (Figure 1.2.5). It is constructed with 
Polysiloxane with PMMA haptics and is available to correct myopia between −2.0 
to −12.0 D. The foldability of the lens permits smaller incisions and the use of a 
suture is not necessarily required226. Thanks to this trait, the Artiflex leads to less 
postoperative induced astigmatism, less spherical aberrations and faster visual 
rehabilitation than the original Artisan lens248,249. Cisneros-Lanuza noted small 
refractile glistenings on many of the Artiflex lenses, although they did not appear 
to affect visual acuity or patient satisfaction250.
Figure 1.2.5: Artiflex lens, 6mm optic
(Courtesy of Ophtec BV)
The location of the Artisan lens, in the anterior chamber between the iris and the 
cornea, has always led to concerns regarding the safety of the innermost cell 
layer of the cornea, the corneal endothelium (Figure 1.2.3). This single layer of 
hexagonal cells serves to dehydrate the cornea and is not capable of regeneration 
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(Figures 1.2.6 a and b). A significant loss of these cells can lead to cornea guttata 
and corneal decompensation. Despite changes to a convex-concave form, 
endothelial cell loss has remained a concern with this lens220,222,251-253. Although 
rare, corneal decompensation has been documented254. Benedetti noted that 
endothelial cell loss was especially significant in the first two postoperative years, 
suggesting operative trauma as the cause of cell loss255. Tehrani advocates 
injecting a bolus of a high viscosity ophthalmic viscosurgical device after the lens 
has been brought into the anterior chamber and before enclavation, to give added 
protection to the endothelium during the implantation procedure256. Though some 
endothelial damage is certainly due the implantation procedure, it is unlikely to be 
the only cause of endothelial cell loss. Eyes with Artisan lenses have been found 
to display endothelial cell loss faster than the natural rate of 0.6% per year255,257. 
Nevertheless, ultrasound and Scheimpflug studies have yet to demonstrate direct 
contact between the pIOL and the endothelium cell layer. Furthermore, the lens 
demonstrates stability in the anterior chamber, although it has been found to 
move forward during accommodation258-262. Kohnen was able to demonstrate that 
the Artiflex lens has a significantly greater distance to the endothelium than the 
Artisan lens, perhaps allowing for more safety against endothelial cell loss263. 
            a                                                                     b
Figures 1.2.6.a. An example of an endothelial cell count measurement, b. an image of 
endothelial cells and a computer-generated depiction to allow for easier counting using the 
Topcon SP-2000 Specular Microscope (Topcon, Tokyo, Japan).
Most likely, there are other, as yet unknown factors that affect the interaction 
between the Artisan lens and the loss of cells in the endothelium. Other recorded, 
yet infrequent, complications associated with the Artisan lens include: traumatic 
dislocation, pigment dispersion, myopic shift, cataract, rise in intraocular pressure, 
endophthalmitis and retinal detachment236,252,264-270. Chronic anterior chamber 
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reaction is rare, although perhaps more common among the Artiflex model of this 
lens259,271,272.
Artisan Lens-power calculations are performed using the Van der Heijde formula, 
taking into account spectacle refraction, corneal power and the depth of the anterior 
chamber208. Nonetheless, residual refractive error is relatively common after pIOL 
implantation. This can be corrected with the use of glasses or contact lenses as 
the anterior part of the eye is left unaffected. More gregarious surgeons combine 
this technique with the excimer laser to correct the remaining ametropia251,273-275. 
1.3 Quality of Life
Refractive surgical procedures have become nearly “everyday” procedures. 
Unlike other common operations such as cataract operations or hip replacement, 
refractive surgery is nearly always performed in healthy eyes. In fact, most 
refractive procedures consider a diseased eye as a contraindication to surgery. 
Generally, studies regarding refractive surgery techniques evaluate the following 
aspects: best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), 
postoperative refractive error (Predictability), Stability of the postoperative refractive 
error, Safety (% eyes with loss of 2 or more lines of BCVA), Efficacy (% eyes with 
UCVA 20/20), Safety Index (mean postoperative BCVA / mean preoperative BCVA) 
and Efficacy Index (mean postoperative UCVA / mean preoperative BCVA)276. 
Although these evaluations are critical to determine the medical success of an 
intervention, positive objective results do not necessarily mean that a patient is 
pleased with the results. Patient-oriented parameters such as patient satisfaction 
and quality of life (QOL) can add a new dimension in evaluating success in 
such procedures, allowing new insights on subjective improvements owing to 
the technique, as well as side-effects and complaints surrounding it. Clinical 
experience certainly provides awareness on many of these questions, however 
quantifying these issues is more concrete. Quantification is especially useful 
considering that eye specialists have been found to underestimate the quality of 
life of their patients277,278. Stein et al., found that ophthalmologists overestimated 
the QOL of patients with respect to cataract and macular disease, yet slightly 
underestimated QOL of patients with glaucoma277. Quality of life measurements 
can lend insight into the effects of disease on patients and can also allow more 
understanding as to how a certain treatment has helped.
The World Health Organization defines the Quality of Life as: “An individual’s 
perception of their position in life, in the context of the culture and value systems 
in which they live, and in relation to their goals, expectations, standards, and 
concerns. It is a broad ranging concept, affected in a complex way by the person’s 
physical health, psychological state, level of independence, social relationships, 
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and their relationship to salient features of their environment279.
Currently, there are two main approaches to quantify QOL:
1.3.1 Choice Based Evaluation Methods
The Time Trade-Off Method is based on the scenario where a patient is asked 
how many years of his remaining life he is willing to trade-off for perfect health/
vision/hearing etc. The Utility-Method is a calculation based on the Time Trade-
Off Method, where 0.0 indicates the worst possible health and 1.0 indicates the 
best possible health. For example, a patient who is expected to live for 20 years 
and is willing to trade 4 of these years for perfect vision will have a Utility Index 
of 20/20 - 4/20 = 16/20 = 0.8). The Standard Gamble Method asks the patient 
how much of a risk he or she would be willing to take to allow for perfect health, 
considering that the treatment which would lead to the cure could lead to either 
perfect health or to death. The Utility Index for someone willing to take a 60% risk 
of death for the chance of perfect health would be 1.0 - 0.6 = 0.4. Quality-Adjusted 
Life-Years (QALYs) combine both the quantity and quality of life produced by 
a medical intervention. It is a product of life expectancy and a measure of the 
quality of the remaining life-years. A QALY places a weight on time in different 
health states. A year of perfect health is worth 1.0; however, a year of less than 
perfect health life expectancy is worth less than 1.0. Death is considered to be 
equivalent to 0.0, however, some health states may be considered worse than 
death and have negative scores (based on Utility Indices). For example, if a 
patient is to survive for one year on Treatment A in moderate health, his QALY 
will be 1 year x 0.5 = 0.5. However, if the patient were to undergo Treatment B 
and would live for 1 year and 3 months, and be in excellent health, his QALY 
would be 1.25 x 1 (excellent health) = 1.25. A patient not receiving any treatment 
would survive 6 months with severe pain and suffering. The QALY would then be 
0.5 (years) x -0.6 (approximately) = -0.3. These numbers would then be used in 
cost-utility analysis to see which treatment is the most beneficial and provides 
the lowest cost per QALY280,281. The advantage of these methods is that they can 
be easily compared with different diseases and also among the diverse medical 
subspecialties. However, they are not very descriptive, and allow for little added 
data information282.
1.3.2 Standardized Questionnaires
Standardized Quality of Life surveys also exist. Examples are the 36-Item Short-
Form Survey (SF-36), Nottinham Health Profile, Symptom Rating Scale, The 
Sickness Impact Profile and The Quality of Well Being Scale277,283. The World 
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Health Organization (WHO) even has their own questionnaire, the WHOQOL-
BREF survey, available in at least eight different languages279. Such scales, in 
their innate generality, allow for easy comparison among different disease states, 
allowing a broad spectrum of disorders to be compared to one another. They are, 
however, generally difficult to translate into utility indexes, making them somewhat 
impractical to apply into clinical practice284. Still, QOL questionnaires give plenty 
of descriptive information about problems that a patient can experience due to a 
disorder.
In Ophthalmology, however, general health QOL questionnaires are of limited use, 
as they provide little to no information on vision-related QOL277,282. Fortunately, 
several different surveys have been developed to study the Quality of Life in 
patients with ocular disease285,286. The National Eye Institute introduced the Visual 
Functioning Questionnaire (NEI-VFQ-25) in 1998. It consists of 25 questions 
with an appendix containing another 12. There are 12 subscales; General 
Health, General Vision, Ocular Pain, Near Activities, Distance Activities, Social 
Functioning, Mental Health, Role Difficulties, Dependency, Driving, Color Vision 
and Peripheral Vision. The questionnaire is scored from 0 to 100, where 0 is the 
worst possible score and 100, the best. The mean score of subscales 2 to 12 
equal the total score. The subscale General Health is used as a control variable 
and does contribute to the total Score. This survey was originally designed for 
patients of different ages with chronic eye disease such as diabetic retinopathy 
and CMV retinitis287-289. However, it has been used to study a broad range of ocular 
ailments, such as uncorrected refractive error, age-related macular degeneration, 
macular holes, optic neuritis and retinal vein occlusion290-294. Predictably, all these 
surveys found that these patients had a significantly lower vision-related quality 
of life than their counterparts without eye disease. Of importance, however, is that 
this research was able to chart which specific problems were being encountered 
by patients with eye disease, and what areas of their lives were being affected 
by it. 
Another questionnaire that has arisen of late is the Refractive Status and Vision 
Profile (RSVP). It consists of 58 questions in the following eight subscales: 
Concern, Expectations, Physical / Social Functioning, Driving, Symptoms, 
Optical Problems, Glare, Problems with Corrective Lenses. Patients rate how 
much difficulty they have with activities using glasses, contact lenses or neither. 
The raw, non-missing scores (from 1 to 5) are converted to a 0 to 100 scale, 
where 0 is the best possible score and 100 the worst. When a patient chooses 
more than one method of correction (glasses or contact lenses), the one with the 
highest score (lowest quality of life) is used. The total score is then calculated 
by averaging all non-missing un-weighted subscales. This questionnaire was 
specifically developed for use among ametropic patients295. 
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Rose and Takashima studied the effects of myopia on the quality of life. Both 
found that patients with high myopia express a lower QOL. This was not only 
related to higher costs, but also to the psychological, practical and cosmetic 
issues associated with higher degrees of myopia296,297. Castanon Holguin also 
found that there were also cosmetic issues among younger patients with myopia. 
Older children, and children residing in more populated areas were more likely to 
demonstrate trepidation about the appearance of glasses or about being teased, 
thus affecting their compliance with spectacle wear298. 
To date, many studies regarding postoperative satisfaction and subjective 
outcomes after refractive surgery have been done. These studies have all shown 
satisfaction with uncomplicated refractive surgical procedures, whereby the 
degree of satisfaction often correlated with postoperative problems such as haze 
and night vision disturbances299-307. In 2007, a comparative study was published 
regarding the Quality of Life among three different groups: Emmetropes, Myopes 
using contact lenses or glasses and Former Myopes who had undergone 
refractive surgery. They found that Emmetropes and the Refractive Surgery 
patients had comparable QOL results, and that the Myopes had significantly 
lower QOL scores308. With the exception of two studies, however, none compared 
preoperative and postoperative results of the same individual patients302,307. So 
far, no study has looked at QOL before and after surgery, and compared these 
results with individuals not seeking refractive surgery.
1.4 Goals of this Thesis
The first part of this thesis aims to evaluate objective results of the Artisan lens. The 
first study discusses the effects of incision-induced astigmatism and the effects 
of planned versus actual positioning of the Toric Artisan pIOL on postoperative 
astigmatism. The second study analyzes the visual results and safety of the 
Artisan lens for hypermetropia. As mentioned previously, hypermetropic eyes 
are especially sensitive due to their small size, possibly making them prone to 
complications not witnessed in myopic eyes implanted with the Artisan lens. 
Thirdly, the long-term effects of the Artisan lens on the corneal endothelium are 
assessed. The relationship between endothelial cell loss and the depth of the 
anterior chamber is evaluated.
The second part of this thesis considers the subjective results of patients with 
myopia in the form of Quality of Life scores. In Chapter 5, satisfied contact lens 
wearers are asked to complete both the RSVP and NEI-VFQ-25 questionnaires. 
The relationship of their scores in relation to their degree of myopia is examined. 
Chapter 6 analyzes the QOL scores of patients undergoing either excimer laser 
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procedures or implantation of the Artisan lens. Patients are given both the RSVP 
and the NEI-VFQ-25 questionnaires before treatment and then again two and 
twelve months postoperative. The Quality of Life scores are then compared with 
each other and with contact lens wearers not seeking refractive surgery (from 
the aforementioned work in Chapter 5), to determine: 1. If the Quality of Life 
improves after refractive surgery 2. If patients seeking refractive surgery have 
poorer preoperative QOL scores than individuals not seeking refractive surgery 
and 3. If the QOL scores of operated (and thus nearly emmetropic) patients are 
higher than myopic contact lens wearers not seeking refractive surgery.
The third part of this thesis looks at unique uses of the Artisan lens. Chapter 7 
involves a case of a child with severe anisometric amblyopia. Due to problematic 
issues with contact lenses, an Artisan lens is implanted in the highly myopic 
eye. The postoperative outcomes are discussed. Chapter 8 is a report on five 
patients having undergone cataract extraction in one eye and, due to the resulting 
anisometropia, an Artisan lens implantation in the other eye. Patients completed 
two postoperative RSVP questionnaires, one in relation to each eye. The results 
of the two are then compared.
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Purpose
To evaluate postoperative astigmatism with regard to incision-induced astigmatism 
and deviation in axial alignment with the use of preoperative limbal marking with 
the Javal keratometer in eyes implanted with the Artisan toric phakic intraocular 
lens (IOL).
Design
Prospective nonrandomized trial.
Participants
Fifty-four eyes of 33 patients with myopia (mean= –9.67 diopters [D]) and 
astigmatism (mean= –3.44 D).
Intervention
The enclavation site was marked on the limbus using the Javal keratometer. 
The Artisan toric phakic IOL was implanted according to the axis marked on the 
limbus. Follow-up was a minimum of 6 months.
Main Outcome Measures
Safety index, efficacy index, predictability, safety, and vector analysis of total 
refractive correction were determined. The effects of axis misalignment and 
incision-induced astigmatism on the final refractive error were evaluated.
Results
At 6 months after surgery, the safety index was 1.29±0.29 and the efficacy index 
was 1.04±0.35. Mean spherical equivalent subjective refraction reduced from 
-11.39±4.86 D before surgery to -0.38±0.57 D at 6 months. Sixty-seven percent 
of eyes were within 0.50 D of attempted refraction and 89% were within 1.00 D. 
Mean preoperative cylinder was 2.92±1.60 D at 91.4°. At 6 months, the mean 
cylinder was 0.28±0.54 D at 174.3°. No eyes lost 2 or more lines of best-corrected 
visual acuity at 6 months. Eighty-three percent of eyes achieved uncorrected 
visual acuity of 20/40 and 28% achieved 20/20. Vector analysis of total surgically 
induced astigmatism revealed a mean cylindrical change of 3.21±1.71 D. Average 
axis misalignment was 0.37±5.34°. The mean incision-induced astigmatism was 
0.74±0.61 D at 0.2°.
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Conclusions
Implantation of the myopic toric IOL leads to safe, efficacious, and predictable 
results. The level of unpredictability caused by minor axis IOL misalignment has 
minimal effects on the residual refractive error. The procedure of axis alignment 
with the Javal keratometer seems to be an accurate method of marking the eye for 
toric IOL implantation. Incision-induced astigmatism can result in an overcorrection 
of the cylinder. A systematic undercorrection of -0.50 D for attempted cylindrical 
outcome could result in an achieved correction closer to emmetropia.
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Achieving emmetropia or other desired refractions is challenging when spherical 
ametropia is combined with astigmatism. Keratorefractive procedures with an 
excimer laser have proven to be accurate for the treatment of mild to moderate 
myopia combined with astigmatism1. Among higher refractive errors, however, 
such procedures can lead to flap complications and irreversible weakening of 
the cornea and problems associated with small optical treatment zones2,3. Over 
the last few years, studies on diverse phakic intraocular lenses (IOLs) have 
demonstrated satisfactory results in the correction of high ametropia4-6. 
The Artisan toric phakic IOL (Ophtec, Groningen, The Netherlands) can be used 
for the combination of ametropia and astigmatism. It is an iris-fixated anterior 
chamber implant of Perspex CQ-UV polymethyl methacrylate with ultraviolet 
filtration (Ophtec). Its overall diameter is 8.5 mm with an optical zone diameter of 
5.00 mm. The myopic toric Artisan IOL is available in half-diopter (D) increments 
with a cylindrical power up to 7.5 D and a spherical power from –3.0 to –23.5 
D. Two models of toric phakic IOLs are available to allow lens insertion on the 
correct axis through a superior or temporal incision, according to the surgeon 
preference. In models A and B, the axis runs through the claws at 0° and 90°, 
respectively. 
Several incision types can be used: corneal, corneoscleral, limbal, or scleral 
tunnel incisions5. Several studies published recently on the outcome of the toric 
phakic IOL have demonstrated satisfactory results7-10. The Artisan lens also 
has been shown to be rotationally stable8,11. However, a drawback of the lens 
is that it requires an incision of 5.2 to 5.5 mm. This incision can induce corneal 
astigmatism.
Precise enclavation of the lens is paramount. Especially in higher degrees of 
astigmatism, minimal misalignment greatly reduces the corrective value of the 
lens. Approximately one third of the cylindrical correction is lost if the IOL is rotated 
10° off the axis12. Some surgeons mark the intended axis of enclavation on the 
iris with the argon or yytrium–aluminum–garnet laser7. Although this procedure 
seems to be accurate, laser burns can cause inflammatory reactions, iris bleeding, 
or endothelial cell loss13,14. Because laser burns must be placed at least 1 week 
before lens implantation, they also create logistical problems. Furthermore, laser 
burns may disappear into the iris folds after enclavation, which preclude the 
evaluation of accurate lens position. Other surgeons use a digital image system 
in which the axis is projected on the iris. This image can be used during surgery 
to find the correct lens position. At our center, the intended position of enclavation 
is marked on the corneal limbus using the Javal keratometer (Haag Streit, Bern, 
Switzerland) directly before anesthesia. 
In this single-center prospective study, we evaluated the safety, efficacy, and 
predictability of the toric Artisan myopia phakic IOL. We further assessed the 
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influence of accurate axis lens placement using corneal markings with the Javal 
keratometer, and studied the effect of astigmatism induced by corneoscleral 
incisions on the total surgically induced refraction.
Patients and Methods
Fifty-four consecutive eyes of 33 patients receiving toric phakic IOLs were enrolled 
in this prospective study. Lens implantations were performed by one surgeon 
(GL) between January 2000 and January 2004. Inclusion criteria consisted of the 
following: (1) general good health; (2) a minimum of 18 years of age; (3) stable 
refraction for a minimum of 1 year; (4) astigmatism more than 1.5 D combined 
with myopia; (5) absence of ocular pathological features; (6) endothelial cell 
count more than 2000 cells/mm2; (7) anterior chamber depth more than 3.0 
mm (including corneal thickness); (8) mesopic pupil size limited to 5.0 mm or 
less, although larger pupils were included after informing the patients about the 
increased risk of haloes and glare. Institutional ethics committee approval and 
informed consent in accordance with the Helsinki Declaration was obtained for 
each patient.
Before preoperative examination, patients were requested to discontinue contact 
lens wear for a minimum of 14 days to avoid the possibility of contact lens-induced 
corneal warpage. The examination included best spectacle-corrected visual 
acuity (BSCVA) in Snellen notation, slit-lamp biomicroscopy, endothelial cell 
count (Topcon SP-2000-P), keratometry (autokeratometer, Topcon KR 7000P), 
A-scan immersion biometry, applanation tonometry, measurement of mesopic 
pupil diameter (Colvard pupillometer), and indirect ophthalmoscopy. Furthermore, 
objective refraction was measured with cyclopentolate hydrochlorate 1.0% 
eyedrops to exclude any accommodative error in subjective refraction. If large 
differences were found between the 2 refractive errors, subjective refraction was 
measured again and used to calculate the power of the lens. The power of the 
IOL, including the intended axis of enclavation, was calculated according to the 
Van der Heijde formula15. Model A was implanted in 53 eyes and model B in 1 
eye. 
When subjective and corneal astigmatism coincided, intended axes were 
marked before surgery onto the corneal limbus with a surgical marker guided 
by the reflected images of the Javal keratometer. If the subjective and corneal 
astigmatism differed, the cornea was marked on the basis of the subjective 
measurements, using the reflected image as a reference point. Myotic drops 
(pilocarpine 4%) were administered to prepare the iris for lens fixation. Surgery 
was performed with retrobulbar anesthesia (41 eyes of 26 patients) or general 
anesthesia (13 eyes of 7 patients), according to the patient needs. 
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A corneoscleral bevelled incision of 5.5 mm was made at the steep meridian and 
2 paracenteses were placed 8 mm apart at either side. The anterior chamber was 
opened and filled with viscoelastic fluid (Healon, AMO, Santa Ana, CA) to maintain 
its depth and to protect the endothelium. After introduction of the lens into the 
anterior chamber with holding forceps (Ophtec REF D02-70), it was positioned 
onto the desired axis and then fixed onto the midperipheral iris stroma with a 
disposable enclavation needle. A slit iridotomy was performed at approximately 12 
o’clock to prevent pupillary block glaucoma; thereafter, the viscoelastic material 
was irrigated manually5. The incision was closed with a 10-0 nylon running suture. 
Tobramycin 0.3% eye ointment was administered once directly after surgery. 
Postoperative treatment included ketorolac and dexamethasone 0.1% eyedrops 
4 times daily for 4 weeks. If both eyes were to be operated on, the interventions 
were separated by a minimum of 2 weeks. 
Follow-up examinations were scheduled at 1 day, 1 week, 1 month, 2 months, 6 
months, and 1 year after surgery, and on a yearly basis thereafter. Postoperative 
examinations included slitlamp biomicroscopy, endothelial cell count (from 
6 months after surgery), keratometry, applanation tonometry, subjective and 
objective refraction, uncorrected visual acuity (UCVA) and BSCVA. Within the 
first 6 postoperative weeks, the suture was dissected or removed if it created 
undesirable corneal astigmatism. After 6 weeks, the suture was removed if 
it caused discomfort or had loosened. At the 1-month follow-up, the Javal 
keratometer was used to determine the postoperative IOL axis alignment. Axis 
misalignment was defined as the difference between intended and achieved axis. 
The postoperative IOL position was measured by paraxial illuminating the IOL 
and projecting the Javal reflections between the claws of the IOL. This was done 
without prior knowledge of the intended axis of implantation (MB). Furthermore, 
patients were asked if they experienced haloes or glare. All data were collected 
prospectively from patient charts.
Statistical Analysis
To analyze BSCVA, UCVA, safety index (mean postoperative BSCVA / mean 
preoperative BSCVA), and efficacy index (mean postoperative UCVA / mean 
preoperative BSCVA), Snellen visual acuity first was converted into logarithm 
of the minimum angle of resolution notation to calculate the mean and then 
transformed back to the geometric mean Snellen visual acuity. Refraction was 
calculated with vector analysis12. The astigmatism vector levels were estimated 
using the mixed model analysis of variance (SAS software; SAS Institute, Cary, 
NC). The model accounts for a possible inclusion of 2 eyes of 1 patient.
Cylindrical refractions were transformed into double-angle vectors and rectangular 
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coordinates as described by Holladay et al12. The double-angle vector plots chart 
the cylinders horizontally (parallel, x-coordinates) and vertically (orthogonal, 
y-coordinates). After calculation, the horizontal and vertical components were 
transformed back to cylindrical notation. Total surgically induced refractive change 
in astigmatism was calculated with the use of vector analysis using cylindrical 
subjective refraction results12.
Incision-induced astigmatism was defined as the vector of the change that 
occurred based on preoperative and postoperative keratometry values. This was 
calculated by first averaging the incision-induced astigmatism of each individual 
eye after 2 months to correct for measurement errors. In this analysis, eyes in 
which additional operations were performed after implantation were excluded. 
Furthermore, the single eye with a model B lens implantation also was excluded, 
because the incision was on the flat axis.
Comparison of data between preoperative and postoperative periods were 
performed with the Student t test for paired data using a level of significance of 
P=0.05. Changes between preoperative and postoperative periods and differences 
between postoperative periods also were analyzed using mixed-model analysis 
of variance using a level of significance of P=0.05.
Results
Patient Population
All 54 eyes of 33 patients were followed-up for a minimum of 6 months. At 1 year, 
follow-up data were available for 45 eyes of 27 patients, and at 2 years, data 
were available for 20 eyes of 14 patients. Mean follow-up was 17.1±11.4 months. 
Twenty-three of the 33 patients were female (69.7%). Mean age was 39.5±2.0 
years (range, 19–57 years). Average axial length was 27.34±0.27 mm (range, 
23.72–32.54 mm), and average anterior chamber depth was 3.66±0.31 mm 
(range, 3.18–4.32 mm). Mesopic pupil diameter averaged 4.7±0.9 mm (range, 
3.0 –7.0 mm).
Visual Acuity and Refraction
Preoperative refractive measurements, along with the postoperative spherical 
equivalent of subjective refraction, UCVA, BSCVA, and percentages of eyes within 
±1.00 D or ±0.50 D of emmetropia at 6 months, 1 year, and 2 years are presented 
in Table 1. The deviation of the achieved spherical equivalent correction from 
attempted spherical equivalent correction at 6 months is presented in Figure 1. 
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Average BSCVA improved significantly after implantation from 0.71±0.23 before 
surgery to 0.88±0.23 at 6 months (P<0.001). A gain of 1 or more BSCVA lines 
was seen in 74.1% of the eyes at 6 months. The safety index after 6 months and 
1 year was 1.29 and 1.26, respectively. The efficacy index was 1.04 at 6 months 
and 1.02 at 1 year. Eighty-three percent of eyes achieved a UCVA of 20/40 and 
28% achieved 20/20.
Figure 1. Plot of attempted spherical equivalent versus achieved subjective spherical 
equivalent at 6 months after surgery. D = diopters; SE = spherical equivalent.
Surgical and Incision-Induced Astigmatism
The  mean preoperative astigmatism using vector analysis was -2.91±1.66 D for 
the horizontal component (x-axis) and -0.15±1.54 D for the vertical component 
(y-axis), equivalent to a cylinder of 2.92±1.60 D at an axis of 91.4°. A double-angle 
minus cylinder plot of preoperative subjective cylinder is presented in Figure 2. 
At 6 months, the total surgically induced refractive change was 3.21±1.71 D at 
an axis of 0.3°. Based on the amount of cylindric correction of the implanted 
IOL, average attempted cylindric outcome was -0.14 D at 180°. Mean achieved 
postoperative astigmatism at 6 months was +0.28±0.57 D for the x-axis value and 
-0.06±0.51 D for the y-axis value, translating to a cylinder of +0.28±0.54 D at a 
mean axis of 174.3° (Fig 3). There was no significant difference in postoperative 
astigmatism between follow-up periods (P=0.13 for the x-axis value and P=0.84 
for the y-axis value). 
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Keratometric data did not change significantly after 2 months, even if suture 
removal took place after this period (Fig 4). The mean incision-induced astigmatism 
was +0.74±0.61 D at a mean axis of 0.2°. Taking into account incision-induced 
astigmatism, mean expected cylindrical outcome changed from –0.14 D at 180° 
to +0.60 D at 180°.
Figure 2. Double-angle plot of minus cylinder of subjective preoperative refraction.
Figure 3. Double-angle plot of minus cylinder of subjective refraction 6 months after 
surgery.
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Axis Misalignment
The mean difference between achieved and intended lens axis alignment was 
0.37±5.34° (range, -13 to +14°). The mean absolute deviation was 4.15±3.34°. 
Axis misalignment is presented in Figure 5. An IOL with a -7.0 D cylinder was 
repositioned owing to a residual cylinder of -1.75 D at 130°, in combination with 
an axis misalignment of 8°. After IOL realignment, a cylinder of -0.50 D at 65° 
remained. Two eyes with cylindrical corrections of -2.00 and -3.00 D, respectively, 
had axis misalignments of more than 10°. No subjective residual astigmatism 
was seen in the first eye, despite an axis deviation of 14°. A deviation of -13° 
from the target axis in the second eye resulted in a residual subjective cylinder 
of -1.00 D.
The average (absolute) spectacle cylindrical error as a result of axis misalignment 
was 0.16±0.12 D. When the known axis deviation for each lens was accounted 
for, the attempted cylindrical correction of -0.14 D at 180° changed marginally to 
-0.15 D at 180°.
Figure 4. Graph showing the mean absolute incisional-induced astigmatism in diopters 
(D) at different follow-up periods.
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Endothelial Cell Loss
The mean preoperative endothelial cell count was 2724±388 cells/mm2 (range, 
1577–3463 cells/mm2). Mean postoperative endothelial cell count was 2779±458 
cells/mm2 (range, 1658–3784 cells/mm2) at 6 months, 2783±475 cells/mm2 
(range, 1658–3591 cells/mm2) at 1 year, and 2717±356 cells/mm2 (range, 2249–
3344 cells/mm2) at 2 years and did not significantly differ from mean preoperative 
values (P>0.45).
Figure 5. Bar graph showing the postoperative deviation in attempted axis of 
enclavation per eye.
Complications
Intervention was uneventful in all patients. One patient experienced a wound 
leak after suture removal at 1 week, requiring resuturing of the incision. One 
patient, with a preoperative asymptomatic retinal break treated with argon laser, 
experienced a retinal detachment 10 days after surgery. At 1 year of follow-up, 
the BSCVA in this eye was 0.40, compared to 0.50 before surgery.
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The mean preoperative intraocular pressure was 15.3±3.4 mmHg. Seven eyes 
experienced a temporary intraocular pressure higher than 21 mmHg within the 
first month of surgery (range, 22–30 mmHg), although this normalized in all eyes 
after discontinuing topical corticosteroids. The mean postoperative intraocular 
pressure (15.7±3.4 mmHg) did not differ significantly from preoperative values 
(P>0.25).
One eye in the study experienced a significant loss of lines after cataract 
developed 1 year after surgery. Visual acuity decreased from 0.4 before surgery 
to 0.2 after surgery. We are not aware of any surgically induced reason for the 
development of the cataract.
No pigment dispersion or pupillary block occurred in any eye during follow-up. 
Seven of the 33 patients noted having more difficulty with haloes or glare. One 
of these patients had a mesopic pupil size larger than 5 mm. All patients were 
satisfied with the outcome of surgery. No patient considered removal of the lens.
Discussion
The safety, efficacy, and predictability of phakic toric Artisan lens implantation 
for the correction of myopia and astigmatism in this study were high. Although 
the toric Artisan lens was investigated in a large European study, the effect of 
axis misalignment and incision-induced astigmatism on the final outcome was not 
analyzed7. Based on our calculations, mean intended astigmatism correction ought 
to have been -0.14 D. However, our study demonstrated a slight overcorrection 
of +0.28 D. By analyzing the effect of incision-induced astigmatism, we found 
that an against-the-rule astigmatism of 0.74 D could be introduced by making 
a 5.5 mm incision on the steep axis. This induced astigmatism also can result 
after cataract surgery16,17. Taking the latter into account, the expected cylinder 
outcome should have been a 0.60 D overcorrection. Instead, we observed an 
overcorrection of only 0.28 D. To evaluate if this discrepancy was a result of axis 
misalignment, we also analyzed its effect on the refractive outcome. We found 
an absolute axis deviation of 4.15±3.34°, comparable with the results of Tehrani 
et al8. Because rotation of the lens has not been observed as a result of its firm 
fixation onto the midperipheral iris stroma, axial misplacement of an iris-claw lens 
must be caused by incorrect alignment of the lens during the surgical procedure. 
Because proper surgical alignment of the IOL is a prerequisite for the success 
of toric phakic IOL implantation, a precise method of axis marking is critical. 
Although most surgeons use preoperative laser iridotomies to mark the axis, we 
used limbal marking with the Javal keratometer in this study. This method does 
not incur the risk of intraocular inflammation and also can be practical, because 
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marking can take place immediately before surgery, avoiding extra patient visits. 
One disadvantage of this method, however, is that the markings can fade or 
disappear during preoperative preparation of the eye. We encountered this in 1 
eye, resulting in an enclavation 14° from the intended axis of implantation. Another 
lens required realignment after developing a subjective postoperative cylinder of 
-1.75 D. The effect of the misalignment on the final cylindrical outcome, however, 
was minimal. The mean attempted cylindrical outcome changed marginally from 
-0.14 D at 180° to -0.15 D at 180° when the known axis error for each lens was 
accounted for. Both the incision-induced astigmatism and axis misalignment could 
not fully explain the discrepancy between the expected and achieved cylindrical 
corrections. Fixed factors such as the lens only being available in half-diopter 
increments and a calibration error of ±0.3 D of the lens itself could have influenced 
the achieved correction. Also, our data are based on subjective refraction only. 
Our impression is that patients tend to experience less astigmatism than was 
objectively observed10. We do not have a good explanation for this interesting 
phenomenon. 
Refractive results in this study however, were predictable and efficacious and 
resembled those achieved by LASIK in lower degrees of myopia and astigmatism1. 
Approximately 90% of the eyes in our study were within 1.00 D of emmetropia. 
These data compare favorably those of LASIK for moderate to high myopia and 
astigmatism, where studies report 41% to 76% of eyes being within the same 
range1,18–22. LASIK, however, tends to result in lower predictability among higher 
refractive errors23,24. The large amount of stromal tissue ablated with the excimer 
laser in these higher degrees of myopia and astigmatism also predisposes eyes 
to corneal ectasia and associated visual problems25. Clear lens extraction with 
toric IOL implantation is another option for such eyes. Studies have shown that 
clear lens extractions carry a higher risk of retinal detachment and further result 
in the loss of accommodation in younger patients26. Moreover, rotational stability 
may be a problem with toric IOLs in the capsular bag27. Compared with LASIK or 
clear lens extraction, the correction of moderate to high myopia with astigmatism 
seems to be safer and more predictable with the implantation of phakic IOLs. 
Furthermore, unlike excimer laser procedures, the eye is not affected by the 
amount of refractive correction. Posterior chamber IOL implantation requires 
a smaller incision (3.2 mm) compared with the toric Artisan lens (5.5 mm)28 
–30. However, reports on phakic toric posterior chamber IOLs for the correction 
of myopia combined with astigmatism currently are limited31. The potential for 
cataractogenesis and pigment dispersion with posterior chamber IOLs is also a 
crucial long-term concern, as is the potential for postoperative lens rotation27,32,33. 
One patient in this study also experienced a cataract, although it is unclear if this 
was the result of the intraocular surgery. 
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In our study, 70% or more of the cases exhibited a gain of 1 or more lines of 
BSCVA. Such improvements in visual acuity also have been reported in other 
studies and have been attributed to the increase in the size of the retinal image 
compared with spectacle correction34–36.
Successful correction of myopia and astigmatism with a toric phakic IOL depends 
on several variables. In this study, we report not only the accuracy of the refractive 
results, but also the refractive contribution of the deviation between intended and 
achieved axis of implantation and the input of incision-induced astigmatism. We 
believe that understanding these parameters will allow greater insight into toric 
phakic IOL implantation.
In conclusion, toric myopic Artisan lens implantation leads to highly predictable, 
effective, and safe results. Marking the enclavation site for toric phakic IOL 
implantation with the use of the Javal keratometer seems to be a safe and reliable 
method. Accounting for incision-induced astigmatism could increase predictability 
further. To compensate for this, a systematic undercorrection of -0.50 D for 
attempted cylindric outcome is advised when using a corneoscleral incision of 
5.5 mm.
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Purpose
We report the postoperative results of the Artisan Hyperopia phakic intraocular 
lens.
Design
Prospective, nonrandomized trial.
Participants
Twenty-six eyes of 13 self-selected patients with refractive error ranging from 
+3.00 to +11.00 diopters (D).
Intervention
Patients with hypermetropia were implanted with the Artisan Hyperopia phakic 
IOL. Mean follow-up was 22.4 months (range 3–36 months).
Main outcome measures
Predictability, stability, efficacy, loss of best spectacle-corrected visual acuity, and 
complications.
Results
At six months, 90.9% (20 of 22 eyes) were ±1.00 D of intended correction and 
81.8% (18 eyes) were ±1.00 D of emmetropia. The mean spherical equivalent 
was stable within 0.25 D during the entire 3-year follow-up period. Twenty-four 
eyes (92.3%) had a postoperative best spectacle-corrected visual acuity of 0.50 
or better at all of their individual follow-up examinations. No patient lost 2 or more 
lines after the procedure. There was a significant negative correlation between 
anterior chamber depth and endothelial cell loss. Two patients experienced 
posterior synechiae with pigment deposits in both eyes. One of these patients had 
convex irides and underwent implant removal within 2 years with a consequent 
clear lens extraction and posterior chamber lens implantation.
Conclusions
Implantation of the Artisan Hyperopic lens leads to accurate and stable refractive 
results with no significant loss of vision. More attention should be paid to convex 
irides and shallow anterior chambers during the preoperative screening to avoid 
unnecessary complications.
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High hyperopia has proven to be a challenge to correct. Procedures with the 
excimer laser have shown great potential, although many authors find that they 
are only safe in cases of low to moderate hyperopia1-5. Thanks to the introduction 
of phakic intraocular lenses (IOL), however, correcting higher degrees of 
farsightedness has now become possible.
Phakic IOLs can be an attractive alternative to other types of refractive 
interventions, such as refractive keratectomy, LASIK, and photorefractive 
keratectomy. Studies on diverse phakic IOLs have demonstrated that visual 
results are stable and predictable6-11. The Food and Drug Administration currently 
is undergoing clinical trials for several different types of hyperopic and myopic 
phakic IOLs (unpublished), although some of these lenses are already being 
used in clinical settings outside the United States6-8,12.
One of these phakic IOLs is the Artisan Myopia lens (model 203W; Ophtec, 
Groningen, The Netherlands), first used clinically in 1986. The competency of 
this lens was scrutinized during the European multicenter study, with refractive 
errors ranging from −5.00 to −20.00 diopters (D) 6. The authors concluded that the 
lens was safe, stable, efficacious and predictable. The first clinical implant of the 
Artisan Hyperopia lens took place in 1992. In this single-center investigation, we 
analyzed the predictability, stability, and visual acuity results of this phakic IOL, as 
well as its possible effect on the corneal endothelium and its rate of complications 
in hyperopic patients.
Materials and Methods
Intraocular Lens
The Artisan Hyperopia lens is an iris-fixated anterior chamber implant made of 
ultraviolet-absorbing clinical quality polymethyl methacrylate, Perspex CQ-UV. 
The lens is vaulted to allow maximum clearance between itself and the cornea 
and the crystalline lens. It has a 5-mm diameter optic with a total length of 8.5 
mm and an absolute height of 1.00 mm. It is available in half-diopter increments 
between +1.00 and +12.00 D.
Patients
Twenty-six eyes of 13 patients (5 female and 8 male) were fitted with the 
Artisan Hyperopia lens implant between May 1996 and June 2000 at Erasmus 
MC in Rotterdam, The Netherlands. Patient age ranged from 28 to 59.5 years, 
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the average being 43.6 years. Preoperative spherical refraction averaged 
+6.80±1.97 D (standard deviation; range, +3.00 – +11.00 D), with an astigmatism 
of −0.67±0.52 D (range, −1.75 – 0.00 D). The mean best spectacle-corrected 
visual acuity (BSCVA) was 0.86±0.59 and ranged between 0.1 and 1.5. Four 
amblyopic patients had a BSCVA of 0.5 and less in one eye each. The mean axial 
length was 21.22±0.79 mm (range, 19.47 – 22.66 mm), and the anterior chamber 
depth average was 3.25±0.25 mm (range, 2.87–3.69 mm). Four eyes (3 patients) 
had an anterior chamber depth of less than 3.00 mm.
All procedures were performed consecutively by the same surgeon (GL). 
Inclusion criteria for the intervention consisted of the following: age more than 18 
years, absence of ocular pathologic features or abnormality, general good health, 
BSCVA more than 0.1, endothelial cell count more than 2000 cells/mm2, anterior 
chamber depth more than 2.6 mm (first 15 months, eight patients) then 3.0 mm, 
fixed pupil size less than 5.0 mm, no surgical difficulty at the time of implantation 
that may increase the potential for complications.
Each patient was informed about the investigative nature of the procedure 
and signed a detailed informed consent form in accordance with the Helsinki 
Declaration.
Intervention
Preoperative examination included a complete slit-lamp examination, endothelial 
cell count (Topcon SP2000-P; Tokyo, Japan), keratometry, applanation tonometry 
(Haag Streit; Bern, Switzerland), and A-scan biometry (Alcon; Irvine, California, 
USA). The objective and subjective refractions were measured with and without 
cyclopentolate hydrochlorate 1.0% eye drops. Both the uncorrected visual acuity 
(UCVA) and the BSCVA were measured (Snellen). The IOL power calculations 
were determined using the Van der Heijde formula6.
One day before surgery, patients were requested to apply gentamicin (Genta 
Mytrex Tramedico, Weesp, The Netherlands) ointment in the eye. Each patient 
received an eyedrop of pilocarpine 4% on the morning of surgery and 30 minutes 
before surgery. The intervention was performed under complete anesthesia until 
mid June 1998 (both eyes of six patients). Thereafter, surgery was carried out 
with local retrobulbar anesthesia, using 5 ml of mepivacaine with hyaluronidase 
(Hyason) and applying pressure with the Honan balloon (Organon, Oss, The 
Netherlands) for a minimum of 10 minutes. The second lens implantation of each 
patient took place 2 to 4 weeks after the first.
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Surgical procedure followed standard protocol. Corneoscleral beveled incisions 
of 5.5 mm were made at 12 o’clock and another two paracenteses were placed 
at 10 and 2 o’clock. The anterior chamber was opened and introduced with 
viscoelastic fluid (Healon) to maintain its depth. After implantation with the use of 
forceps (model D02-72, Ophtec, Groningen, The Netherlands), the lens was fixed 
onto the iris with an enclavation needle (model OD125, Ophtec). At the end of the 
operation, a slit-iridotomy was performed at 12 o’clock, the corneoscleral wounds 
were closed with a running suture (Ethilon 10.0), and the viscoelastic material 
was manually irrigated.
Follow-up examinations took place 1 day, 1 week, 1 month, 3 months, 6 months, 
and 12 months after surgery, and on a yearly basis thereafter. Patients with 
complications were examined more frequently. To be included in this study, 
patients required a minimum 3-month follow-up. Patients were contacted by mail 
with an appointment date to ensure completeness of follow-up. One patient died 
after 2 years and thus was lost to follow-up.
For any given comparison of preoperative and postoperative data, the preoperative 
average included only the group of eyes depicted in the given postoperative period. 
To evaluate the stability of the procedure more precisely, we also separately 
analyzed eight eyes that were present at every examination for all 3 years.
Postoperative examinations included slit-lamp biomicroscopy, applanation 
tonometry, manifest refraction, UCVA, and BSCVA. Postoperative specular 
microscopy was performed at every follow-up after 3 months. All data were 
collected prospectively from patient charts during follow-up examinations by the 
ophthalmologists (GL and ML) and their assistants.
Both eyes of each patient were analyzed separately. We performed regression 
analysis and t tests (P = 0.05) using the SPSS statistical program. To analyze 
BSCVA and UCVA results, Snellen visual acuity was first converted into logarithm 
of the minimum angle of resolution notation to calculate the mean and then 
transformed back into Snellen visual acuity.
Results
Mean follow-up was 22.4 months per patient. All 26 eyes were followed-up for 
1 month, 21 eyes for 3 months, 22 for 6 months, 17 for 1 year, 15 for 2 years, 
and 10 for 3 years (Table 1). Eight eyes with a 3-year follow-up attended every 
examination. Average preoperative measurements are noted in Table 1 along with 
postoperative spherical equivalent, BSCVA, UCVA, and endothelial cell counts.
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Refraction
The preoperative subjective spherical equivalent ranged from +3.00 to +11.00 
D, with a mean of +6.80±1.97 D (standard deviation). The average spherical 
equivalent was −0.16±0.61 D at 1 month after surgery, −0.04±0.78 D at 3 months, 
and −0.08±0.74 D at 6 months. At 1, 2, and 3 years after surgery, the averages 
were −0.03±0.71 D, −0.15±0.89 D, and +0.10±0.85 D, respectively (Fig 1 and 
Table 1). One eye with no evidence of cataract or other pathologic features 
changed more than 1.00 D in refraction between 1 month and 3 years.
At 6 months, 13 eyes (59.1%) were ±0.50 D of intended correction and 19 eyes 
(86.4%) were within ±1.00 D (Fig 2). There was a significant correlation between 
intended and achieved correction (R = 0.87; P < 0.0005). Thirteen eyes (59.1%) 
were corrected within ±0.50 D of emmetropia, and 18 eyes (81.8%) were corrected 
within ±1.00 D. All eyes were within ±2.00 D of intended correction and emmetropia 
throughout the investigation. Four eyes required lenses stronger than what was 
available (from +12.50 to +14.70 D). Five other eyes would have benefited from 
half-diopter incremented lenses, which were not being manufactured at the time 
of surgery, so that the intended refraction of 2 eyes was −0.50 D and the intended 
refraction of 3 eyes was +0.50 D. Three eyes whose preoperative refraction was 
more than +12.00 D achieved a final refraction of more than +1.00 D. There were 
no correlations between predictability and the following: preoperative refraction, 
axial length, anterior chamber depth, and endothelial cell counts. 
The spherical refraction of the four patients who attended every check-up 
averaged −0.22±0.76 D after 1 month, −0.23±0.86 D at 3 months, −0.09±0.72 D 
at 6 months, −0.11±0.72 D at 1 year, −0.27±0.99 D at 2 years, and −0.05±0.85 D 
at 3 years (Fig 1). 
Figure 1. Stability in 3-year period postoperative refraction over a 3-year period (n = 21 
at 3 months, n = 22 at 6 months, n = 17 at 12 months, n = 15 at 24 months, n = 10 at 36 
months).
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Visual Acuity
Mean preoperative BSCVA was 0.86±0.59. After surgery, the average BSCVAs 
were 0.86±0.67 at 1 month, 0.82±0.65 at 3 months, 0.87±0.67 6 months, 0.82±0.27 
at 1 year, 0.82±0.59 2 years, and 0.75±0.52 at 3 years (Table 1). There were no 
significant differences between the preoperative and postoperative BSCVAs.
Postoperative BSCVA was unchanged or better in 80.8% of the eyes (21 eyes) at 
1 month, 85.7% (18 eyes) at 3 months, 86.4% (19 eyes) at 6 months, 82.4% (14 
eyes) at 1 year, 80.0% (12 eyes) at 2 years, and 50.0% (5 eyes) at 3 years. Figure 
3 shows the number of Snellen lines gained and lost at 6 months and 3 years 
after surgery. No eyes lost 2 or more lines throughout our investigation.
A BSCVA of 0.50 or better was achieved by 92.3% of the eyes (24 eyes) at 1 
month, 95.2% (20 eyes) at 3 months, 95.5% (21 eyes) at 6 months, and 94.1% 
(16 eyes) at 1 year. In the second year, 93.3% (14 eyes) could see equal to or 
better than 0.50, and 80.0% (8 eyes) could see equal to or better than 0.50 in the 
third year (Table 1). A BSCVA of 1.00 or better was achieved by 73.1% of the eyes 
(19 eyes) at 1 month, 57.1% (12 eyes) at 3 months, 50% (11 eyes) at 6 months, 
58.8% (10 eyes) at 1 year, 60.0% (9 eyes) at 2 years, and 40.0% (4 eyes) at 3 
years. 
Figure 2. Intended versus achieved correction 6 months after the implantation of the 
Artisan Hyperopia phakic intraocular lens in 22 eyes.
Intended VS Achieved Correction at Three to Six Months 
Postoperative (n=26) 
12,00
Achieved Correction (D)
  
0,00
2,00
4,00
6,00
8,00
10,00
0,00 2,00 4,00 6,00 8,00 10,00 12,00
Intended Correction (D)
Overcorrection
Undercorrection
Artisan for Hypermetropia 69
Figure 3. Gain and loss of Snellen lines change in best spectacle-corrected visual acuity 
after implantation of the Artisan phakic intraocular lens (model 203W; Ophtec, Groningen, 
The Netherlands). There were no significant loss of Snellen lines (loss of two or more 
lines) throughout the investigation.
The average UCVA was 0.73±0.68 at 1 month, 0.66±0.66 at 3 months, 0.65±0.65 
at 6 months, 0.63±0.62 at 1 year, 0.59±0.60 at 2 years, and 0.58±0.57 at 3 years. 
There were no significant differences in UCVAs among the different time periods 
(Table 1).
Six months after surgery, 20 eyes (90.9%) could see 0.50 or better uncorrected, 
and 5 eyes (22.7%) could see 1.00 or better.
Endothelium
Up to and including the first year after the procedure, we noted gains in the 
postoperative corneal endothelial counts ranging from 1.0% to 3.8%.  After 2 
years, there was a decrease of 8.5% from the mean preoperative cell count,
and there was a decrease of 11.7% after 3 years. There was a significant loss 
of endothelial cells between the 3-year postoperative endothelial cell count
and 1-month and 1-year postoperative cell counts, even when we corrected for 
different patient groups (P < 0.05). However, there were no significant differences 
between the preoperative and any of the postoperative results. We found a 
significant negative correlation between endothelial cell loss and the depth of the 
anterior chamber at 3 months (P < 0.05) and 2 years (P < 0.01). 
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Although a trend toward this was also present in the other time periods, results 
were not significant. Before surgery, there was no correlation between the 
endothelial cell count and anterior chamber depth (P = 0.45).
Complications
Two patients experienced posterior synechiae and pigment cell deposits on the 
crystalline lens of both eyes 2 weeks after surgery. Patient 1, 49 years of age, 
experienced no clinical symptoms and remained stable all 3 years (Fig 4). 
Patient 2, 59.5 years of age, experienced posterior synechiae at nearly all clock 
hours with a fixed pupil size of 2.5 mm. She described her vision as “like looking 
though a pinhole,” although her BSCVA remained at 1.00 (Fig 5). She chose to 
have the lenses removed, and underwent clear lens extractions in both eyes; the 
first eye 4 months after the initial intervention, and the second after 2 years.
None of the 13 patients reported halos or glare in either eye. 
Figure 4. A dilated pupil with pigment dispersion on the crystalline lens and posterior 
synechiae from 4 o’clock to 5 o’clock and again from 7 o’clock to 11 o’clock.
 
Figure 4. A dilated pupil with pigment dispersion on the crystalline lens and 
posterior synechiae from 4 o’clock to 5 o’clock and again from 7 o’clock to 11 
o’clock. 
 
Figure 5. Pigment dispersion on the crystalline lens and posterior synechiae 
encircling the pupil. This patient subsequently underwent implant removal and 
a clear lens extraction and thereafter, a posterior chamber lens implantation in 
both eyes. 
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Figure 5. Pigment dispersion on the crystalline lens and posterior synechiae 
encircling the pupil. This patient subsequently underwent implant removal and 
a clear lens extraction and thereafter, a posterior chamber lens implantation in 
both eyes. 
i re 5. Pigment dispersion on the crystalline lens and posterior synechiae encircling th  
pupil. This patient subsequently underwent implant removal and a clear lens extraction 
and thereafter, a posterior chamber lens implantation in both eyes.
Discussion
We achieved a predictability of 88.5% (23 of 26 eyes) within 1.00 D of intended 
correction. Only 2 eyes of a patient (1.79 D and 1.45 D of overcorrection) and 
a single eye of another patient (1.49 D of overcorrection) were not within ±1.00 
D of intended correction. The individual overcorrected in both eyes did have the 
longest axial length and the third deepest anterior chamber from all the patients; 
however, neither of these factors nor a ratio thereof showed a correlation with 
predictability. We believe, therefore, that other yet unknown factors may play an 
important role in determining the postoperative refractive outcome.
Compromises in correction are a general problem encountered with all lens 
implants. In our case, the Artisan lens is produced minimally in half-diopter 
increments and up to a maximum of +12.00 D. Nine of 26 eyes were not fitted 
with lenses that would have ideally corrected their vision. The 4 eyes that required 
lenses stronger than that available were the most undercorrected (postoperative 
spherical refraction between +0.63 and +1.38 D). Patients requiring corrections 
of smaller increments had to settle for a minor overcorrection or undercorrection. 
Nonetheless, at 6 months, 20 of the 22 eyes (90.9%) requiring lenses up to 
+12.00 D saw within ±1.00 D of emmetropia.
Artisan for Hypermetropia 73
The mean spherical equivalent remained within 0.25 D during the 3 years of follow-
up. However, because not all patients were present at each of the examinations 
and their follow-up was not of equal length, we decided to examine 8 eyes of 4 
patients who were present at every follow-up examination. The greatest difference 
we found among this group was 0.22 D between years 2 and 3. Three of the 8 
eyes (3 of 4 patients) increased in refraction (two from −1.00 to −0.50 D and one 
from emmetropia to +0.75 D). One of these patients, however, did not experience 
a reduction in visual acuity in the same time frame. A longer follow-up may be 
required to determine the cause of this change.
All but a single patient had a postoperative BSCVA 0.5 or higher until the third 
year of the investigation, when the BSCVA of another patient dropped from 0.5 
to 0.4 (from a preoperative 0.5). The one patient who remained at less than 0.5 
throughout the investigation was amblyopic. Her preoperative BSCVA was 0.1 
and improved to 0.2 after phakic IOL implantation.
The mean postoperative BSCVA at every examination period was better than the 
mean preoperative BSCVA, indicating that, on average, the Artisan Hyperopia 
phakic IOL improved the BSCVA. Comparing the mean postoperative UCVA 
to the preoperative BSCVA led to less positive results and indicated that many 
patients still benefited from glasses or contact lenses after acquiring the implant. 
As mentioned before, ideal corrections were hampered by the availability of the 
lens of the exact corrective error. More importantly, however, is that hyperopic 
patients experience a smaller image size when their refraction is corrected, 
thereby limiting postoperative BSCVA improvement. This may explain why 
patients implanted with the Artisan lens for myopia saw, on average, better without 
correction after surgery than they did before surgery with correction and that the 
hyperopic patients did not6-8.
The Artisan lens maintains a relatively favorable position in the eye. As long as 
the anterior chamber is deep enough, the lens keeps a healthy distance from the 
corneal endothelium and avoids the posterior chamber completely. Still, anterior 
chamber implants do run the risk of damaging the corneal endothelial layer, 
mostly through intraoperative trauma or through rubbing of the eyes. There were 
no significant differences between preoperative and postoperative endothelial 
cell counts in our study, even after correcting for different groups of patients. 
Nevertheless, our investigation did indicate a loss of 11.7% after 3 years. Even 
after correcting for a naturally occurring decrease of 0.6% a year, endothelial 
cell loss remained high (10.1% after 3 years), indicating that endothelial cell loss 
remains a cause for concern. Also, we found a significant negative correlation 
between endothelial cell loss and the anterior chamber depth at 3 and 24 months, 
although not at any other period. The increased loss of cells in shallower anterior 
chambers may have been the result of the endothelium undergoing more trauma 
during the implantation process and thereafter, although the inconsistencies 
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among the different periods and in the endothelial counts themselves indicate 
that further investigation is required. Nevertheless, we propose that a minimum 
anterior chamber depth of 3.0 mm be incorporated in the inclusion criteria, 
instead of the current 2.6 mm recommended by the manufacturer. Fechner et al 
made same recommendation when studying a similar iris-fixated lens and further 
suggested a minimum anterior chamber depth of 3.5 mm in younger patients, 
considering that the depth decreases with increasing age11,14. This may prevent 
endothelial damage during surgery and the complications mentioned above.
The most serious complication we encountered was the appearance of pigment 
deposits on the crystalline lens of both eyes of two patients, along with posterior 
synechiae. We found that the asymptomatic patient, patient 1, had convex irides. 
The constant contact of the lens with the iris could have created the complication. 
We could not find a satisfactory explanation for the synechiae of patient 2 because 
ophthalmologic examination showed no further abnormalities and surgery had 
proceeded without any complications. The anterior chamber depths and axial 
lengths of their eyes were at neither extremes of the ranges measured within 
our group of patients. Patient 1 had an anterior chamber depth of 3.30 mm in 
both eyes and an axial length of 20.60 and 21.20 mm in the left and right eye, 
respectively. Patient 2 had an anterior chamber depth of 3.00 mm in both eyes 
with axial lengths measuring 21.10 and 21.40 mm in the respective left and right 
eyes. The only common factor between the 2 patients is that they were both 
operated under general anesthesia; however, four other patients with the same 
form of anesthesia did not experience this complication. During the American 
Food and Drug Administration trials of the same lens, 2 of the 14 eyes taking part 
in the study experienced analogous problems. Furthermore, an eye had a fibrin 
pupillary membrane 6 weeks after surgery. These complications were ascribed 
mainly to the implantation procedure (unpublished). These findings emphasize 
that special care should be taken to avoid disturbing the internal structures of 
the eye during surgery and that careful preoperative screening is required with 
hyperopic eyes, which tend to be smaller, have shallow anterior chambers, and 
have a higher frequency of convex irides. After we began regarding convex irides 
as a contraindication, we no longer encountered such complications. We also 
advise that iris abnormalities, such as convex irides, likewise be considered 
contraindications for anterior chamber lenses in general.
Conclusions
The Artisan Hyperopic phakic IOL provides predictable, stable, and efficacious 
results in patients with high degrees of refractive error, with minimal loss of 
BSCVA. Strict patient screening is necessary to prevent complications. Further 
study on long-term complications, endothelial cell loss, and stability with a greater 
number of eyes is required.
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Objective
To report endothelial cell densities (ECDs) and their correlation to anterior 
chamber depth (ACD) after implantation of the Artisan intraocular phakic lens.
Design
Prospective observational case series.
Participants
Three hundred eighteen eyes of 173 myopic patients treated with the Artisan iris-
fixated phakic intraocular lens (IOL).
Methods
Eyes with an ACD ranging between 2.89 and 4.50 mm were implanted with 
the Artisan phakic IOL. Endothelial cell density measurements were performed 
preoperatively and at each follow-up examination using a noncontact specular 
microscope.
Main Outcome Measures
Endothelial cell density (cells per square millimeter).
Results
Follow-up ranged between 1 (82 eyes) and 7 years (13 eyes) (mean, 35.3±20.7 
[standard deviation] months per eye). After 3 years, there was a significant loss 
in ECD (P≤0.03). At 5 years, mean observed endothelial cell loss was 8.3% 
(5.3% corrected for a natural endothelial cell loss of 0.6% a year). Endothelial cell 
density loss remained progressive throughout our follow-up period. After 3 years, 
a significant negative correlation between ACD and endothelial cell loss was 
revealed (P≤0.03). Patient age, gender, refractive error, incision size, and side of 
the eye were not correlated to ECD loss. All corneas remained clear throughout 
the study.
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Conclusion
After 3 years, a significant ECD loss was revealed. This ECD loss was significantly 
negatively correlated to the ACD. We therefore suggest that eyes just meeting 
the minimum ECD requirement have greater ACDs to compensate for possible 
greater endothelial cell loss and that patients with shallow anterior chambers have 
higher ECDs. Artisan phakic lens implantation in young eyes narrowly meeting 
the minimum criteria of endothelial cell density (2000 cells/mm2) and ACD (2.6 
mm) should perhaps be reevaluated, due to longer exposure to higher rates of 
endothelial cell loss.
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The Artisan lens was first introduced by Worst in 1978 for aphakic eyes under 
the name Iris Claw. In 1986, refractive surgeons began to implant the iris-fixated 
lens in phakic myopic eyes. Thereafter, developments also led to lenses for the 
correction of hyperopia and mixed astigmatism. More recently, a foldable version of 
the lens, the Artiflex, was introduced. Multicenter clinical trials have demonstrated 
that these lenses are safe and have a high efficacy1-3. However, from the time 
of its use, there have been concerns that this anterior chamber (AC) lens could 
damage the endothelial cell layer due to its close proximity to the cornea4-5. In 
fact, an earlier biconcave model was modified to a convex–concave lens for this 
reason6. The manufacturer advises the use of the Artisan lens only in eyes with 
an endothelial cell density (ECD) > 2000 cells/mm2 and an AC depth (ACD) > 2.6 
mm (from the corneal epithelium to the crystalline lens). Furthermore, patients 
are advised not to rub their eyes after lens implantation, as possible warping 
of the peripheral cornea may cause the endothelial cell layer to rub against the 
intraocular lens (IOL). Still, most studies have not revealed significant endothelial 
cell loss, although most had relatively short follow-ups3,7-9. Our previous research 
in hyperopic patients demonstrated an inversely proportional relationship between 
the ACD and endothelial cell loss in our 3- and 12-month follow-ups10. 
In this study, we examine the long-term relationship between ACD and endothelial 
cell loss in myopic eyes.
Materials and Methods
The following inclusion criteria were used in this study: ACD > 2.6 mm; ECD > 
2000 cells/mm2; pupil (in scotopic light conditions) < 6 mm; stable refractive error 
for a minimum of 1 year; no corneal, iris, or pupil abnormalities; and general good 
health. Eyes having undergone more than one operation were excluded from 
analysis after their subsequent procedure.
Preoperative examinations included subjective and objective refractive error 
with and without cyclopentolate 1.0% eyedrops, best-corrected visual acuity 
(Snellen), Javal keratometry, applanation tonometry, slit-lamp examination, 
fundus examination, and ECD. The ACD (distance between corneal epithelium 
and crystalline lens) and axial length were measured by A-scan immersion 
biometry using OcuScan (Alcon, Irvine, CA). The results from the ultrasound 
with the highest and straightest peaks from 10 different measurements (with a 
standard deviation of ≤7) were used. All ECD measurements were performed on 
an SP-2000P unit (Topcon, Tokyo, Japan). These were based on photographs 
of the central cornea. Between 1996 and 2002, these consisted of the average 
of 2 manual ECDs where the center of a minimum of 50 cells was marked 
(center or dot technique). If there was a large difference between the 2 counts, 
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another ECD measurement would be performed. After 2002, we used automated 
measurements with the retracing method by means of the IMAGEnet software 
program (Topcon), with the same specular microscope11. All complete cells on 
the image were used to measure the cell density. The value of 0.6% per year was 
used to estimate natural endothelial cell loss12. 
Each patient was informed about the procedure and signed a detailed informed 
consent form in accordance with the Helsinki Declaration. The lens power was 
calculated using the van der Heijde formula. All lens implantations were performed 
according to protocol by one experienced surgeon (GPML)10. We received 
approval from the institutional review board/ethics committee of our institution for 
this study.
Statistics
We used paired Student’s t tests to test for differences between preoperative 
and postoperative endothelial cell densities. A mixed model analysis of variance 
was applied to determine a relationship between endothelial cell loss and ACD, 
correcting for the factors age, gender, left or right eye, refractive error (higher 
power IOLs are thicker), and lens type (Artiflex, 5.0 mm, and 6.0 mm). Spatial 
correlation structure of the repeated measurements within an eye was employed. 
SAS for Windows software (SAS Institute, Cary, NC) and SPSS statistical software 
(version 11.0, SPSS Inc., Chicago, IL) were used for data analysis.
Results
Patient demographics are listed in Table 1. Three hundred eighteen eyes implanted 
with the Artisan Myopia Claw Lens of 173 patients with a minimum follow-up 
of 1 year were included. Patients were operated between February 1997 and 
September 2004. Mean follow-up was 35.3±20.7 months per eye. Patients were 
excluded from the study after they had undergone lens exchange (n = 5), cataract 
extraction (CE) (n = 4), or retinal detachment surgery (n = 1) or experienced a 
pupillary block glaucoma (n = 1). The surgeon (GPML) chose to include one eye 
with an ECD of 1993 cells/mm2 (which narrowly missed the inclusion criteria) 
after conferring with the patient. Data of some of these eyes have been published 
in previous reports2,3,8. 
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Table 1. Patient Population Demographics (318 Eyes, 173 Patients)
Table 2 shows the endothelial cell loss between 3 months and 7 years 
postoperatively. There is an initial yet insignificant rise in endothelial cells in the 
first postoperative year. Endothelial cell loss was significant from 3 years onwards, 
also when corrected for an expected natural cell loss of 0.6% per year12.
Figures 1-8 display the relationship between ACD and ECD, corrected for patient 
age, refractive error, gender, left or right eye, and lens type. After 3 years, a 
significant negative correlation was revealed.
All corneas remained clear throughout our follow-up period. There were no 
significant differences in endothelial cell loss between the 3 different lens types 
(Artiflex, 5 mm, and 6 mm require incisions of 3.2, 5.2, and 6.2 mm, respectively). 
Age and gender of the patient and refractive error of the lens (difference in lens 
thickness) did not show a correlation with endothelial cell loss, nor did the side 
of the eye.
Discussion
In our study, we found a significant endothelial cell loss in our patient population 
starting at 3 years after implantation of the Artisan iris-fixated phakic IOL. 
Endothelial cell loss in our population, 8.3% (5.3% when correcting for natural 
loss), was relatively higher than that of other studies13-16. However, some of these 
studies had a relatively shorter follow-up13, 14, 16. Additionally, similar to other 
reports, there was an initial yet insignificant increase in cells the first postoperative 
year1, 7, 10, 16. Though we did not account for this preoperatively, we believe that 
the increase in ECD may have been caused by endothelial cell migration from 
the peripheral to the central cornea after contact lens discontinuation by some 
of our patients, although this pattern of cell distribution has been disputed17-19. 
Moreover, ECD measurements have been found to be less accurate immediately 
postoperatively20. The size of the incision did not appear to play a role in cell loss, 
Table 1: Patient Population Demographics 
 
 
 
Patient Population  
        (318 eyes, 173 patients) 
 
Age (years)   38.5 ± 10.1 (range 18 – 61) 
Male   34.1 % 
Mean Spherical Refractive Error (Diopters)   -12.25 ± 4.20 (range –1.00 to –23.50) 
Mean Anterior Chamber Depth (mm)   3.70 ± 0.30 (range 2.89 to 4.50) 
Mean preoperative Endothelial Cell Density (cells / mm2)   2817 ± 356 (range 1993 to 3979) 
Type of Lens (number)       5.0 mm   152 (57 toric) 
                                              6.0 mm   149 
                                              Artiflex   17 
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Figure 1. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 
6 months postoperatively (n = 248). Mixed model analysis of variance (P>0.05) is 
corrected for patient age, refractive error, gender, left or right eye, and lens type.
Figure 2. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 1 year 
postoperatively (n = 251). Mixed model analysis of variance (P>0.05) is corrected for 
patient age, refractive error, gender, left or right eye, and lens type.
Endothelial Cell Change versus Anterior Chamber Depth at 6 Months Postoperative (n=248)
Mixed Model Anova, p>0.05
-1000
-800
-600
-400
-200
0
200
400
600
800
1000
2,50 3,00 3,50 4,00 4,50 5,00
Anterior Chamber Depth (mm)
En
do
th
el
ia
l C
el
l C
ha
ng
e 
(P
re
op
er
at
iv
e 
-
Po
st
op
er
at
iv
e)
 (c
el
ls
/m
m
2)
 
 
Figure 1: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell nsity) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
Figure
Endothelial Cell Change versus Anterior Chamber Depth at 1 Year Postoperative (n=251)
Mixed Model Anova, p>0.05
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Figure 2: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endotheli l cell density - post perative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
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Figure 3. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 2 years 
postoperatively (n = 168). Mixed model analysis of variance (P>0.05) is corrected for 
patient age, refractive error, gender, left or right eye, and lens type.
Figure 4. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 3 years 
postoperatively (n = 122). Mixed model analysis of variance (P = 0.03) is corrected for 
patient age, refractive error, gender, left or right eye, and lens type.
Endothelial Cell Change versus Anterior Chamber Depth at 2 Years Postoperative (n=168)
Mixed Model Anova, p>0.05
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Figure 3: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
 
Figure
Endothelial Cell Change versus Anterior Chamber Depth at 3 Years Postoperative (n=122)
Mixed Model Anova, p=0.03
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Figure 4: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
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Figure 5. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 4 years 
postoperatively (n = 69). Mixed model analysis of variance (P = 0.002) is corrected for 
patient age, refractive error, gender, left or right eye, and lens type.
Figure 6. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 5 years 
postoperatively (n = 51). Mixed model analysis of variance (P = 0.0001) is corrected for 
patient age, refractive error, gender, left or right eye, and lens type.
Endothelial Cell Change versus Anterior Chamber Depth at 4 Years Postoperative  (n=69)
Mixed Model Anova, p=0.002
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Figure 5: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
 
Figure
Endothelial Cell Change versus Anterior Chamber Depth at 5 Years Postoperative (n=51)
Mixed Model Anova, p=0.0001
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Figure 6: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
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Figure 7. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 6 years 
postoperatively (n = 28). Mixed model analysis of variance (P = 0.0001) is corrected for 
patient age, refractive error, gender, left or right eye, and lens type.
Figure 8. Relationship between anterior chamber depth and endothelial cell loss 
(preoperative endothelial cell density [ECD] − postoperative ECD) per patient at 7 years 
postoperatively (n = 13). Mixed model analysis of variance (P<0.0001) is corrected for 
patient age, refractive error, gender, left or right eye, and lens type. 
Endothelial Cell Change versus Anterior Chamber Depth at 6 Years Postoperative (n=28)
Mixed Model Anova, p=0.0001
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Figure 7: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
 
Figure
Endothelial Cell Change versus Anterior Chamber Depth at 7 Years Postoperative (n=13)
Mixed Model Anova, p<0.0001
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Figure 8: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
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reinforcing previously reported results14. Other studies on the Artisan lens do 
confirm our findings of progressive endothelial cell loss4, 5. Continued endothelial 
cell loss has also been noted in pseudophakic eyes 10 years after CE21. 
Furthermore, we found a significant negative correlation between ACD and 
loss of endothelium. Menezo et al also found a correlation with ACD after 6 
months of their 4-year endothelial study and noted significant postoperative 
endothelial cell loss. As the cell hexagonality remained stable after 2 years, 
loss of endothelium was attributed to the implantation procedure rather than to 
the lens itself. The correlation between ACD and cell loss after half a year was 
considered to be a possible consequence of intraoperative contact15. In our study, 
the negative correlation between endothelial cell loss and ACD only became 
evident after 3 years and remained significant up to our 7-year follow-up. The 
factors mentioned previously, as well as corneal wound reorganization, may have 
blurred a relationship between ACD and decrease in ECD in earlier postoperative 
years15,22.
One patient with preoperative ECDs of 2910 (right eye) and 2706 (left eye) had 
ECDs of 586 (right) and 863 (left) after 7 years with clear corneas. Serial ECD 
measurements made the first postoperative year (7 times) showed a continual 
progressive loss; however, the greatest ECD loss occurred between years 1 and 
2 (before the switch to IMAGEnet). We could not explain the dramatic decrease 
in ECD, as the corneas were unremarkable preoperatively, as were the implant 
procedures. The patient did not rub his eyes and was not known to have allergies. 
He did undergo uncomplicated strabismus surgery on both eyes within 1 year of 
Artisan lens implantation, although the procedures took place after the greatest 
amount of cell loss had already taken place.
We performed endothelial cell counts using the center or dot technique before 
2002 and the retracing method thereafter11. Thus, the cell measurements of our 
longer follow-up patients were calculated using 2 different counting methods on 
the same specular microscope. On regular inspection, the calibration was checked 
but showed no differences before and after 2002. Although significant ECD loss 
was only noted after 3 years of follow-up (whereby some patients were operated 
before we switched to the IMAGEnet program), a similar pattern of loss was 
found among our hyperopic patients, with whom all follow-up examinations took 
place before the IMAGEnet system was being used10. Nonetheless, it has been 
demonstrated that the center or dot technique is not as precise as the retracing 
method, which could question the accuracy of our (preoperative) measurements, 
although these could have been both underestimated or overestimated11. Analysis 
of cell hexagonality and polymegathism would have strengthened this study, but 
unfortunately, these data were not available on most eyes operated before 2002. 
Endothelial Cell Change versus Anterior Chamber Depth at 6 Years Postoperative (n=28)
Mixed Model Anova, p=0.0001
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Figure 7: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
 
Figure
Endothelial Cell Change versus Anterior Chamber Depth at 7 Years Postoperative (n=13)
Mixed Model Anova, p<0.0001
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Figure 8: Displays the relationship between the anterior chamber depth (mm) and endothelial cell loss (cells/mm2) (preoperative 
endothelial cell density - postoperative endothelial cell density) per patient. The Mixed Model Analysis of Variance (ANOVA) is 
corrected for patient age, refractive error, gender, left or right eye and lens type.  
 
Figure
             Chapter 490
The study is further limited by the number of patients available for follow-up 
examinations; at 3 years, data from only 122 of the 318 eyes were available, and 
at 7 years, from only 13. This partial follow-up was due to the majority of patients 
having been operated on more recently, whereby the data are not yet available.
Although our study showed significant endothelial cell loss, all of the corneas 
remained clear. Still, we do find the cell loss noteworthy and offer an approach to 
the inclusion criteria other than what the manufacturer advises. First, considering 
the progressive endothelial cell loss we encountered, we recommend lifelong 
patient follow-up. Patients should be made aware of this before being operated. 
We further suggest a stricter inclusion criteria for younger patients, proposing 
ACDs of ≥3.5 mm. This could offset the decrease in ACD with age, which we 
have found to be 0.12 mm/decade (Cheng YYY, Bhagwandien ACE, Wolfs 
RCW, Luyten GPM, submitted for publication, 2006). Moreover, it could partially 
compensate for cell loss after lens implantation. Analogous suggestions were also 
made by Fechner et al in 199823. Most importantly, we advise that some of the 
inclusion criteria no longer be looked at individually but as a whole: patient age, 
ACD, and ECD should be considered jointly. For example, young patients with 
relatively shallow ACs and ECDs just above 2000 cells/mm2 should perhaps no 
longer be considered for implantation of these lenses. Longer follow-up studies 
of endothelium cell loss in relation to the ACD are necessary before definitive 
criteria, including patient age, can be reasonably determined. We suggest that 
surgeons use their clinical judgment when assessing young potential candidates 
narrowly meeting the inclusion criteria for the Artisan phakic IOL.
Our study showed a significant progressive endothelial cell loss after 3 years 
and a significant negative correlation between endothelial cell loss and ACD. We 
suggest caution in operating young patients who narrowly meet the inclusion 
criteria for ACD and ECDs.
ECD After the Artisan Lens 91
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Anisometropic Amblyopia and the Artisan Lens 131
High unilateral myopia is difficult to treat in young children and often leads to 
anisometropic amblyopia1–5. Factors such as the depth of the amblyopia and the 
age of the patient play a key role in the effectiveness of treatment. Success is 
also frequently hampered by practical problems such as those created by glasses 
and contact lenses. Thus far, however, patient compliance has been considered 
the greatest therapeutic impediment6,7. In such cases, refractive surgery with the 
excimer laser or phakic intraocular lens (IOL) implantation can be a solution. 
There is, however, limited experience in treating myopic children with these 
procedures1,2. 
As excimer laser corrections are confined to refractive errors of approximately 
-8.00 to -10.00 diopters (D), effective surgical correction of high myopia in 
children can only be done with phakic IOLs. Studies of phakic IOLs to correct 
anisometropic amblyopia in the pediatric population have been reported3–5. 
Concerns about IOL implantation in young patients include cataract formation, 
pupil alteration, endothelial cell loss, postoperative inflammation, and a possible 
myopic shift as the patient ages.
Artisan phakic IOL implantation is a reliable and safe procedure in adults8,9. 
Although the IOL is considered experimental in several parts of the world, it has 
been implanted in patients in The Netherlands since 1991. Thus, when we were 
confronted with a young anisometropic amblyopic patient with restricted treatment 
options, we decided to correct his high unilateral myopia using the Artisan phakic 
IOL. Recently, Chipont and coauthors reported such a case with an 18-month 
follow-up5. Here, we present a patient with 3-year postoperative results.
Case Report
A 4-year-old boy with high unilateral myopia and distinct anisometropic amblyopia 
in the right eye presented in February 1997. Thirty minutes after 2 drops of 
cyclopentolate 1%, the child had a cycloplegic refraction of -14.00 +3.00 x115 in 
the right eye and was emmetropic in the left eye. The cycloplegic best corrected 
visual acuity (BCVA) in the myopic eye was 0.17 (Amsterdam Picture Chart 
[APK], translated from the Dutch, Amsterdamse Plaatjeskaart). Stereoscopic 
vision could not be detected. A spectacle was prescribed with a -10.00 +3.00x115 
correction in the right eye and plano in the left eye along with 2 hours a day of 
left-side occlusion therapy. A refractive undercorrection was deemed necessary 
to reduce the effects of aniseikonia.
In June 1997, the BCVA in the right eye, measured with a full correction of -14.00 
-3.00 x 115, had improved to 0.83 (APK); however, stereovision remained negative 
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(Lang and Titmus fly tests). Nonetheless, the patient reported that glasses were 
uncomfortable as they were constantly lopsided; he therefore refused to wear 
them. This lack of cooperation made it difficult to continue the patch therapy, and 
the BCVA with full correction had decreased to 0.56 (APK). Thus, a toric contact 
lens of -11.50 +2.50 x 110 was prescribed for the right eye.
After wearing the lens for 2 months and increasing the daily occlusion therapy to 
8 hours, the patient had a poor BCVA at 0.50 (APK); however, the Titmus test was 
positive. Furthermore, during this period, the boy repeatedly lost his contact lens. 
Considering that neither glasses nor the contact lens had proved to be worthwhile 
therapy, refractive surgery was considered. The case was discussed thoroughly 
in our department and with Jan Worst, MD, the creator of the lens. A decision 
was made to correct the unilateral refractive error with an Artisan phakic IOL and 
to continue occlusion therapy. Considering the lens had only been studied in 
adults, the possible short- and long-term complications reported in the literature 
were discussed with the child’s parents, who were told its use in children was 
experimental. As they were unhappy with their son’s varying progress, they 
agreed to the operation and signed an informed consent. The aim was slight 
myopia so that both eyes would eventually have about equal refractive errors. 
The hope was that further changes in error would occur concurrently in both eyes 
as the patient grew. 
In February 1998, the patient had a -15.00 D Artisan phakic IOL (model 206w; 
5.0 mm optic) implanted in the right eye under general anesthesia. The surgical 
procedure and the IOL power calculation were performed according to standard 
protocol. The patient received gentamicin ointment 1 day before the procedure. 
Pilocarpine 4% drops were applied the morning of and 30 minutes before 
surgery. A bevelled 5.5 mm corneoscleral incision was made at 12 o’clock, and 2 
paracenteses were placed at 10 o’clock and 2 o’clock. The anterior chamber was 
opened and filled with sodium hyaluronate 1% (Healon) to maintain its depth. 
After the IOL was implanted with a DO2–72 forceps (Ophtec), it was fixated to 
the iris with enclavation needles (model OD125, Ophtec). At the end of surgery, a 
slit iridotomy was performed, the corneoscleral wound was closed with a running 
suture, and the viscoelastic material was manually irrigated. Gentamicin ointment 
was applied to the eye. 
The early postoperative period was without complications. Occlusion therapy 
was continued for 8 hours a day. Four months postoperatively, the cycloplegic 
subjective refraction was -1.50 +1.00 x 135 in the operated eye and -1.00 in the 
left eye. Snellen BCVA (E chart) was 0.65 and 0.80, respectively. At 29 months, 
the cycloplegic subjective refraction was -0.75 +0.75 x 155 in the operated eye 
and -2.00 in the left eye. Stereovision had improved (positive Lang Test of 600” 
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repeated 4 times; TNO plates I and II). The Snellen BCVA (E chart) was 0.70 and 
1.00 in the right eye and left eye, respectively. At 26 months, the refraction remained 
unchanged but the BCVA was 1.00 in both eyes. Three years postoperatively, 
the slitlamp showed a healthy crystalline lens with a clear, well-centered phakic 
IOL. The cycloplegic refraction in the right eye was plano+0.75 x 160 and in left 
eye, -2.75 +0.25 x 35. The patient now wears spectacles to correct the refractive 
error. The Snellen BCVA (numerical chart) is 1.2 and 1.0 in the operated eye and 
unoperated eye, respectively.
Although the patient was initially too young and uncooperative for a preoperative 
endothelial count, the cell density was 3196 cells/mm2 (SP-2000-P specular 
microscope, Topcon) 1 year postoperatively and 3111 cells/mm2 at 19 months. 
At the final examination, the endothelium showed normal hexagonal cells (Figure 
1); however, the cell density had decreased by 11.9% to 2741 cells/mm2. A 
comparison of the cell count with that in the unoperated eye measured on the 
same day (3302 cells/mm2) showed a 17% difference. Before this, no endothelial 
cell counts in the left eye had been performed. 
Figure. Endothelium in the operated eye 3 years postoperatively. The cells have 
maintained a normal hexagonal shape and have a mean cell density of 2704 cells/mm2 ± 
118 (SD).
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Discussion
Treating high anisometropic amblyopia is frequently disappointing. Amblyopic 
treatment is encumbered by several problems6,7. Although children are usually 
capable of compensating for aniseikonia caused by high anisometropia, 
full spectacle correction is not generally prescribed. Glasses have practical 
hindrances such as prismatic effects. In addition to our patient’s complaint of 
the glasses being lopsided on his face, there are cosmetic issues and glasses 
provide far from ideal binocular vision. Contact lenses minimize the magnification 
differences between the eyes but can be difficult to manage in young children10. 
Therefore, resistance to spectacles and contact lenses may negatively influence 
the treatment of amblyopia in many cases. However, even after a young patient’s 
refractive error has been surgically corrected, one must always emphasize that 
patch therapy must be diligently continued.
The European multicenter study of the Artisan phakic IOL in 518 adult eyes 
established a safety index (postoperative BCVA/preoperative BCVA) of 1.31 and 
an efficacy index (postoperative uncorrected visual acuity/preoperative BCVA) 
of 1.03 3 years postoperatively8. We found similar results in our study9. As the 
lens is safe and has a good, predictable refractive outcome, we decided to use it 
to correct the patient’s refraction even though it has not been extensively tested 
in children. The child’s refusal to wear the glasses and repeated loss of his 
contact lens were affecting patch therapy compliance. Thus, we believed that the 
problems created by glasses and contact lenses outweighed the possible risks 
created by IOL implantation. By correcting the anisometropia with the Artisan 
lens, amblyopia treatment was facilitated by encouraging the patient to use the 
highly myopic eye and increasing occlusion therapy compliance. We believe this 
allowed the patient to develop stereovision. However, different optotypes were 
used preoperatively and postoperatively. Experience with the methods of visual 
acuity measurement and increasing patient cooperation may have distorted the 
amount of visual improvement. 
Our patient was too young to allow valid preoperative endothelial cell measurement; 
however, comparison between the operated and un-operated eye 3 years after 
IOL implantation revealed a 17% difference. Earlier postoperative cell counts 
reveal much higher densities, indicating that rapid cell loss occurred after 19 
months. We surmise that the child had begun rubbing his eyes, although we could 
not definitely establish this. During the multicenter investigation of the Artisan 
lens in adults, an initial endothelial cell loss of 4.8% was detected, which levelled 
off to 0.7%8. This rate of decline is not significantly different from that found in 
the general population. In our own series of adult myopic eyes treated with the 
Artisan phakic IOL, we observed no endothelial cell loss9. Basti et al. report no 
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difference in short-term corneal endothelial cell loss between adult and pediatric 
cataract patients, although it is questionable whether this comparison is valid 
among patients with an anterior chamber lens; in these cases, the endothelial 
layer can be affected when patients rub their eyes11. Therefore, endothelial cell 
loss remains a cause of concern in pediatric patients with an Artisan IOL.
Although intraocular surgery in children is more delicate and prone to inflammatory 
reactions, there were no adverse reactions or complications in our case. In a 
similar case of Chipont and coauthors, a low degree of uveitis was detected5. 
It is, nonetheless, possible that the complication rate in this younger population 
is higher as the clearance between the lens and the corneal endothelium can 
decrease over time12. The patient could also become more myopic with age, in 
which case additional correction with glasses or contact lenses can be prescribed. 
In more extreme cases, the lens can be exchanged. In our case, the postoperative 
refractive outcome was still stable at the patient’s last examination at 3 years. 
Studies in which anisometropic amblyopia was treated with photorefractive 
keratectomy yielded promising results in children with myopia1,2. Nonetheless, 
excimer procedures are limited to low and moderate myopia, leaving phakic IOLs 
as the only feasible surgical option for young patients with high myopia. 
BenEzra and coauthors and Lesueur and Arne treated anisometropic amblyopia 
with phakic posterior chamber IOLs. Although they achieved positive results, 
posterior chamber IOLs can have serious complications including angle-closure 
glaucoma, cataract, and chronic inflammation, all of which require fastidious long-
term follow-up3,4. One advantage of a posterior chamber IOL is the reduced risk 
of corneal endothelial cell loss, which is especially beneficial in children prone to 
rubbing their eyes4. The angle-supported phakic anterior chamber IOL, another 
alternative to iris-fixated IOLs, can also lead to complications such as retinal 
changes and pupil ovalization13. Furthermore, eye growth can compromise the 
stability of the lens, making it an inappropriate choice in developing eyes.
The Artisan lens has not shown early serious complications; however, long-
term follow-up results are not available. In our patient, the Artisan phakic IOL 
was effective in treating anisometropic amblyopia. Although the IOL can provide 
viable correction of high unilateral myopia in children, its implantation should be 
considered only if conventional therapy fails.
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Purpose
To determine the visual outcome and the quality of life of five bilaterally myopic 
unilateral cataract patients implanted with a phakic intraocular lens (pIOL) in their 
sound eye.
Methods
Refraction and Snellen visual acuity were measured before and after undergoing 
both phacoemulsification in one eye and pIOL implantation in the other. Patients 
(3 presbyopic) completed the Dutch translation of the Refractive Status and 
Vision Profile (RSVP) for each eye after undergoing both procedures. Follow-up 
was between 6 and 18 months.
Results
Postoperatively, 4 out of 5 patients were within 1.00 D of emmetropia in the 
pseudophakic eye and all 5 out of 5 patients were within 1.00 D of emmetropia 
in the pIOL implanted eye. The safety index of the phakic eyes was 1.40 and 
the efficacy index was 0.88. There were no significant differences in the quality 
of life subscale measurements nor in their total scores (p>0.05). Patients 
significantly preferred reading with their phakic eye than with their pseudophakic 
eye (p=0.02).
Conclusion
PIOLs are an option for bilateral myopic patients with unilateral cataract. A larger 
study needs to be conducted to verify if presbyopic patients prefer reading with 
their phakic eye.
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At present, unilateral cataract patients with myopia may choose to adjust their 
nearsightedness while undergoing cataract surgery.  However, once their eye is 
treated to (nearly) full refractive correction, highly bilateral myopic patients are 
rendered substantially anisometropic.  Contact lenses are certainly an option, 
although not all patients adjust to them well.  Some patients desire more enduring 
solutions, so that they may have similar refractive errors in both eyes at all 
times.
Many such permanent alternatives are currently available for myopes.  Not only 
can they consider the Excimer laser, but also phakic intraocular lenses (IOLs) and 
clear lens extractions (CLE).  As our experience with the Artisan lens has been 
encouraging in both bilateral and unilateral implantations, we felt that this phakic 
IOL would be an interesting option for five relatively young patients with unilateral 
cataract1-3. Pure objective postoperative measurements, however, could not allow 
evaluation of how the patients experience the unique situation of pseudophakia 
in one eye and a phakic IOL in the other. To gain insight into this, the five patients 
postoperatively completed the Refractive Status and Visual Profile (RSVP), a 
vision-related quality of life questionnaire, for each eye4,5.
In this report, we discuss the objective and subjective results of five bilaterally 
myopic patients who underwent a cataract extraction and posterior chamber lens 
implantation in one eye and an Artisan phakic IOL implantation in the other.
Methods
Phacoemulsification and Artisan lens implantation preoperative examinations 
and procedures were performed according to standard protocol3. The following 
pseudophakic IOLs were used: three AMO SI40 foldable lenses (Allergan 
Medical Optics, Nieuwegein, the Netherlands), one Acrysof foldable lens (Alcon, 
Gorinchem, the Netherlands) and one polymethyl methacrylate (PMMA) lens 
(Flex 652, Domilens, Lyon, France). All operations were performed by G.L. unless 
otherwise noted.
Objective and subjective refractions were measured with and without the use of 
cyclopentolate hydrochlorate 1.0% eye drops. Both the uncorrected visual acuity 
(UCVA) and the best spectacle corrected visual acuity (BSCVA) were converted 
from the Snellen to the logarithmic logMAR notation to calculate the mean and 
then reverted back to Snellen notation. IOL power calculations were determined 
using the Van der Heijde formula1,2.
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To assess the subjective aspect of the treatment, patients received two copies 
of the Dutch consensus translation of the RSVP. Patients were asked to fill 
out the categories of the two identical questionnaires (concerns, expectations, 
functioning, driving, symptoms, optic problems, glare, and problems with glasses 
/ contact lenses) simultaneously, so as to be able to compare their eyes. The total 
score is an average of the eight subscales, which are all weighted equally. The 
RSVP contains a total of 58 questions4,5.
Questionnaires were sent out between six and twenty months after Artisan 
lens implantation. All five patients responded within two weeks. Statistics were 
performed on the Microsoft Excel Program.
Case Reports
Preoperative and postoperative refractions and BSCVAs are noted in Table 1. 
Patient 1
The patient was a 54-year-old male bilateral high myope with a nuclear cataract 
in his right eye. In August 2000, an Allergan SI40 lens of 13 D (6.0 mm optic) was 
implanted in this eye after undergoing phacoemulsification. His left eye was fitted 
with a 6.0 mm -8.5 D Artisan lens two weeks later. At one month postoperative, the 
refraction was S+0.50 C-1.50 x 22 in the pseudophakic eye, with a corresponding 
BSCVA of 0.70. The patient required a YAG capsulotomy in October 2000 and 
was diagnosed the following month with a local rhegmatogenic retinal detachment 
(RD) in the same eye, created by a tear in an area of lattice degeneration. The 
RD was reattached by scleral buckling (encircling band and scleral buckle) (M.V.) 
after which the eye had a refraction of S plan C -2.00 x 10 and a BSCVA of 0.70. 
One year later, the BSCVA of the right eye could be improved to 1.00 with a glass 
of S -1.25 C -1.50 x 2. The refraction of left eye remained stable throughout at S 
–0.75 C –0.25 x 142 with a BSCVA of 1.00.
Patient 2
Patient two was a 51-year-old bilaterally myopic male with a distinct astigmatism 
in the right eye and a nuclear cataract in his left eye, which created a monocular 
diplopia. Phacoemulsification was performed and an Allergan SI140 NB lens (6.5 
mm optic, 11 D) was implanted in the eye to correct the problem in January 2001. 
The following week, a toric Artisan lens with S-7.5 x -3.00 D was implanted in the 
right eye. Nine months later, the patient’s UCVA was 1.00 in his right eye and 0.80 
in his left. A glass of S +0.75 C-0.50 increased the visual acuity in his left eye by 
two lines.
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Patient 3 
A 54-year-old male high myope had a bilateral myopic retinal degeneration and 
a cortinuclear cataract in his right eye. After phacoemulsification, his eye was 
suited with an Acrysof 6.0 mm foldable lens (8 D) in May of 2000 (K.T.). Two 
weeks hereafter, the refraction in his phakic eye was corrected with an Artisan 6.0 
mm lens (-10.5 D). Although his visual acuity remained relatively low due to retinal 
pathology, his VA had improved by two Snellen lines in his pseudophakic eye and 
by three lines in his phakic eye when examined eighteen months postoperative. 
Patient 4 
This 33-year-old colour-blind male myope was diagnosed with a nuclear cataract 
causing monocular diplopia. As the vision in the eye deteriorated, the patient 
was treated for his cataract with phacoemulsification and lens implantation (FLEX 
652, 6.5 mm optic, 9 D). Two months later, his right eye underwent a phakic lens 
(Artisan 6.0 mm, -9.5 D) implantation. The last check-up six months postoperative 
showed no abnormalities and stable refraction in both eyes. His pseudophakic 
eye could achieve a visual acuity of 1.60 without correction.
Patient 5
A highly myopic female patient 37 years of age was diagnosed with a conjunctival 
MALT lymphoma in her right eye. As a consequence of radiotherapy, the eye 
developed keratoconjunctivitis sicca and required punctum plugs on the upper and 
lower lacrimal ducts two and again three years after the initial diagnosis. During 
this last examination, a posteriocapsular cataract was also diagnosed in this 
eye. The patient underwent phacoemulsification and lens implantation (Allergan 
SI40 NB, 12 D) three months later. Postoperative complaints of aniseikonia with 
the use of spectacles led to the myopia in her left eye being corrected with the 
Artisan 6.0 mm lens (-10.0 D) four months hereafter. Six months postoperative, 
the patient had a stable refraction and a BSCVA of 1.00 or higher in each eye.
Four of the five patients had a postoperative BSCVA of 1.00 or higher in their 
pseudophakic eye, three of the five patients were within 1.00 D of emmetropia and 
all five within 2.00 D. All patients were within 1.00 D of emmetropia in their Artisan 
implanted eye and three within 0.50 D. Three of the five phakic eyes showed a 
postoperative improvement in their BSCVA and the other two were unchanged at 
1.25. The safety index (mean postoperative BSCVA / mean preoperative BSCVA) 
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was 1.40. The efficacy index (mean postoperative UCVA / mean preoperative 
BSCVA) was 0.88.
RSVP Questionnaire
There were no significant differences between the eyes in any of the subscales of 
the RSVP (Table 2). The eyes with the Artisan lens scored on average better in the 
subscales concerns, functioning, symptoms and glare, while the pseudophakic 
eyes were, on average, better for driving. There were no differences noted by any 
of the patients in the subscales expectations, optic problems and problems with 
glasses/contact lenses.
Two different total scores were calculated, one including all the subscales and 
one disregarding the subscales “expectations” and “problems with glasses and/or 
contact lenses”, as these two subscales are dependent on the individual patients 
and not on the individual eyes. The difference between the average scores of the 
eyes then increased by one point, but remained insignificant (Student’s paired 
t-test, p>0.05).
In all but one question, patients experienced no average significant difference 
between the phakic and pseudophakic eyes. When asked to rate their satisfaction 
with reading and near vision, 4 of the 5 patients expressed a preference for their 
phakic eye while one preferred neither (patient 3) (p=0.02).
Discussion
When a relatively young highly myopic patient develops a cataract in one eye, it 
is questionable if he or she will be willing to or even should undergo an operation 
in their phakic eye. Aversion to yet another operation, not wanting to risk their 
other eye, being satisfied with their current method of correction or electing for 
monovision are all reasons for leaving the healthy eye untouched. However, 
some patients may find their anisometropia troublesome, albeit only having to 
deal with it until they put on their corrective lenses. Certain patients may not be 
able to tolerate contact lenses and will have to deal with aniseikonia with the use 
of spectacles. Yet others may just want to have their refractive error about the 
same in each eye permanently. Our five patients with unilateral cataract had the 
myopia of their sound eye corrected with the Artisan lens.
Three of the five pseudophakic eyes were within 1.00 D of emmetropia, and all 
five within 2.00 D. All patients showed an improvement in visual acuity and all 
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but one pseudophakic eye had a BSCVA of 1.00 or higher. The remaining patient 
had improved his visual acuity by two Snellen lines, but it remained low due to 
the myopic macular degeneration. These results are comparable to large-scale 
investigations on phacoemulsification6. Refractive results of the Artisan implanted 
eyes were also comparable with more extensive studies1,2.
Table 2.   RSVP subscale and total scores: Higher scores indicate more problems.  *The 
subscales “expectations” and “problems with glasses/contact lenses” are not included in 
the corrected total score.
 
 
 
 
RSVP Questionnaire Average Score (%) 
Subscales Pseudophakic Eye Artisan Lens Eye 
Concerns 23 21 
Expectations 30 30 
Functioning 13 8 
Driving 8 15 
Symptoms 21 11 
Optic problems 7 7 
Glare 16 6 
Problems with glasses / 
contact lenses 0 0 
Total (100) 15 12 
Corrected Total* 15 11 
 
Table 2.   RSVP subscale and total scores: Higher scores indicate more 
problems.  *The subscales “expectations” and “problems with glasses/contact lenses” 
are not included in the corrected total score. 
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RSVP
The Refractive Status and Visual Profile Questionnaire survey led to some 
interesting results. The patients only experienced one significant difference 
between their eyes – they preferred reading with their phakic eye. Such a distinction 
was not made for vision in general (with or without refractive correction). Although 
this partiality would seem reasonable considering that their preferred eye was 
their only phakic eye, one must note that two of the four patients who expressed 
this preference were above the age of fifty. Their partiality for the phakic eye 
could indicate that one should consider leaving the healthy lenses of presbyopic 
patients intact and not opt for a clear lens extraction too early, although a much 
greater number of patients would need to be assessed to be able to conclude 
this. The one patient of 54 years who felt he read equally well with both eyes 
(Patient 3) suffered from bilateral macular degeneration and recorded only one 
difference between the eyes throughout the whole questionnaire: his vision was 
more often cloudy or foggy in his phakic eye.
As a group, there were no significant differences among the eyes in any of the 
subscales. While it appeared that, on average, patients had more problems 
driving with their Artisan eye, this difference lay in one individual, Patient 4, who 
had a confirmed higher visual acuity in his pseudophakic eye. They also tended 
to function better with their phakic eyes, however this was due to two patients 
who had had troublesome pseudophakic eyes (patient 1 and 5, with RD and 
keratoconjunctivitis sicca respectively). Although the bulk of the difference in the 
subscale “symptoms” is due to patient 5 (with keratoconjunctivitis sicca in her 
cataract operated eye), 4 out of 5 patients noted a difference in their “vision being 
cloudy or foggy”. Three experienced more trouble with their pseudophakic eyes 
and one (Patient 3) with his Artisan implanted eye. Patient 4 did not record any 
difference.
One shortcoming of our small RSVP survey is that the questions were not also 
posed preoperatively. This would have allowed a quantitative measurement of 
the change in vision-related quality of life. In addition, patients should have been 
asked to complete the questionnaire during identical postoperative periods, 
instead of between six and eighteen months after Artisan lens implantation. Further 
variability was also incurred by the periods between the cataract treatment and 
pIOL implantation, which varied between one week and four months. Moreover, 
the sample size was limited.
Before selecting the Artisan lens to correct the refractive error for the healthy 
eye, all possible options available were discussed with the patients. Clear lens 
extraction (CLE) and implantation of a multifocal lens, which would have rendered 
both eyes pseudophakic with similar refractions, were considered. However, as 
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CLEs increase the risk of retinal detachment in myopic eyes, they were rejected7. 
The postoperative RSVP results also indicated that CLEs may not be ideal for 
younger presbyopes, considering that two of our three patients above the age 
of fifty favoured reading with their Artisan-implanted eye and did not show this 
preference for vision in general. Posterior chamber phakic IOLs, on the other 
hand, do retain accommodation in young patients, however they too may have a 
higher rate of RD and can also induce pupillary block glaucoma and cataract8,9. 
LASIK could have been performed in our patients with refractive errors less than 
-10.00 D.
Previous positive experience with the Artisan lens led to its choice1-3. Furthermore, 
preoperative biometry for pseudophakic lens implantation could be performed 
reliably with the Artisan lens in place if a cataract was to develop. Removal of the 
iris-fixated lens, phacoemulsification and pseudophakic lens implantation could 
then also take place in one procedure.
This case series demonstrates the possibility of using the Artisan lens for 
anisometropia after the treatment of unilateral cataract in myopic patients. The 
five patients undergoing this treatment significantly preferred reading with their 
eye implanted with the Artisan pIOL, without displaying the same preference for 
their vision in general. More patients need to be considered before definitive 
conclusions can be made.
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The methods of correction of refractive errors have evolved immensely, especially 
throughout the 20th Century. “Coke Bottle” glasses are no longer the norm for 
persons requiring refractive correction. Technological improvements in lens 
development have allowed for thinner glasses, although this has not been able 
to alleviate the change in image size associated with higher refractive errors. 
Contact lenses do surmount this problem, and due to improvements in materials, 
allow for more tolerability and longer wear. Nevertheless, contact lens intolerance 
due to allergy or over-wear still exists. For these patients, and for those seeking 
freedom from contact lenses or spectacles, refractive surgery has been able to 
provide many answers. 
This thesis studied many different aspects surrounding refractive surgery and 
has many clinical consequences associated with it: 
The evaluation of the toric Artisan lens displayed excellent visual results with 
reliable axial alignment of the lens. The observation of consistent incision-
induced astigmatism of nearly two thirds of a Diopter led to advice on fine-tuning 
postoperative astigmatism by systematically correcting for the incision-induced 
astigmatism. We were also able to demonstrate that our method of using the Javal 
keratometer to mark the corneal limbus before the operation leads to relatively 
precise surgical alignment of the lens. A larger series of patients and a study on 
whether pre-emptively correcting the incision-induced astigmatism leads to more 
precise astigmatic correction is advised.
Our study of hypermetropic eyes revealed that the Artisan lens for hypermetropia 
achieves excellent visual results. However, the appearance of posterior synechiae 
in 15% of the eyes (4 of 26) and eventual removal and phacoemulsification of 
clear lenses in nearly 8% of the eyes (2 of 26) suggests that these eyes are 
more prone to postoperative problems than myopic eyes receiving the Artisan 
lens. These last eyes had convex shaped irides. Special preoperative attention 
to the anatomy of hyperopic eyes can prevent these complications. Furthermore, 
the indication of an inverse relationship between anterior chamber depth and 
endothelial cell loss prompted our seven-year follow-up study on endothelial 
cell density (ECD) and the Artisan lens. Further analysis is required to see if 
implementation of our advice does in fact lead to less endothelial cell loss.
The significant relationship between endothelial cell loss and the anterior chamber 
depth helped to better understand why some eyes suffer a more profound ECD 
loss. This awareness also allowed us to advise surgeons to assess their patients 
differently to what the manufacturer advises. Instead of simply checking if the 
patient meets all the different requirements for lens implantation, we suggested 
that certain aspects should be evaluated concurrently; young patients just 
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narrowly meeting the inclusion criteria for ECD and anterior depth should perhaps 
no longer be considered for the Artisan lens to avoid severe endothelial cell loss 
or even corneal decompensation in the distant future. Supplementary research is 
required to identify the mechanism behind this relationship and which relationship 
of anterior chamber depth, endothelial cell density and age should keep a surgeon 
from operating.
The Vision-Related Quality of Life (VR-QOL) surveys identified 4 key points: 
1. Myopia is negatively correlated with VR-QOL. 
2. Patients seeking refractive surgery have a lower VR-QOL than those not 
seeking refractive surgery, mainly due to their no longer wanting to wear contact 
lenses or glasses and their not wanting the problems associated with them. This 
suggests that more comfortable and convenient methods of refractive correction 
could dissuade some patients from undergoing refractive surgery.
3. After undergoing uncomplicated refractive surgery, VR-QOL increases.
4. Despite Excimer laser surgery and a nearly emmetropic postoperative state, 
these patients, on average, do not score better on certain VR-QOL surveys than 
patients who have not permanently corrected their myopia. This implies that there 
may be some inherent differences between these two patient populations.
Further analysis is required to identify which patients would benefit most, and 
which patients would benefit least from refractive surgery.
The good visual results of the Artisan lens implanted in a four-year old boy with 
unilateral high myopia are very encouraging. This can be an option for refractory 
cases with severe patient compliance issues. Still, many more cases with 
longer follow-ups extending into adulthood or later are needed before long-term 
complications (especially regarding corneal endothelial cell loss) can be excluded 
and refractive surgery can be deemed safe in the pediatric population.
The five-patient case report studying the independent RSVP scores of individual 
eyes demonstrated that adult patients (presbyopic or nearly presbyopic) show 
virtually no preference for a myopic eye corrected with a pseudophakic lens after 
phacoemulsification or corrected with an Artisan lens. However, there remains 
a preference to read with the phakic eye. Although this study is small, it does 
demonstrate that reading with a phakic eye is preferred to a pseudophakic eye. 
This may help to evaluate patients seeking refractive surgery who are considering 
clear lens extractions. Maintaining some degree of accommodation may be the 
preferred route if the crystalline lens is clear.
To this day, no refractive surgeon can guarantee 20/20 vision without correction 
in the healthiest of eyes. Much more research on the known and as yet unknown 
stumbling blocks of refractive surgery is required before it can be perfected. 
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More precise lens calculations and algorithms provide better results everyday, 
as does progress in technology such as smaller incisions, better quality lasers 
and instruments. In addition, advancements in research, such as the genetic and 
environmental factors surrounding refractive errors could lead to sound preventive 
treatments and measures to prevent ametropia. More research regarding Vision-
Related Quality of Life can help to guide surgeons in their quest for excellence.
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Pioneer Harold Ridley faced much ostracism when his new invention, the intraocular 
lens, was introduced half a century ago. He recounted some comments he had 
received throughout the years about his intraocular lens during the Gullstrand 
Lecture, in Stockholm, Sweden, 1993 (as published in Trivedi et al., Sir Nicholas 
Harold Ridley. He changed the world, so that we might better see it. Indian J 
Ophthalmol 2003;51(3)211-6.)
‘Dr. Ridley, Why don’t you… GO HOME!’ 
(Philadelphia)
‘Would you have one of THESE THINGS put in your son’s eye?’ 
(Oxford) 
‘As long as I remain in charge of this department no implant will ever be done’
(European Professor of Ophthalmology) 
‘This operation should never be done’ 
(Chicago)
‘It offends the first principle of ophthalmic surgery and could cause malignant 
disease’ 
(USA)
‘Rayners should be prosecuted for supplying intraocular lenses’ 
Ridley eventually had his invention placed in his own eye and suffered only minor 
complications. 
Needless to say, the world’s perspective on the intraocular lens has changed. No 
doubt the inventors of tomorrow will also be facing such reactions. If these future 
innovators can persevere and look past the criticism, it will undoubtedly lead to 
newer and fresher developments in Ophthalmology and change the field of eye 
care.
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Summary 
The phakic Artisan lens is an intraocular lens (IOL) that can be implanted in the 
anterior chamber of the eye to correct nearsightedness, farsightedness and/or 
astigmatism, without having to remove the natural lens of the eye. This lens can 
be an ideal option for eyes that are not suitable for other methods of refractive 
surgery, or for patients who are not comfortable undergoing technically irreversible 
surgical interventions. This thesis examines the visual results of the Artisan lens 
implanted in hypermetropic and astigmatic eyes and its effect on the corneal 
endothelium. Also, it investigates the Vision-Related Quality of Life (VR-QOL) 
of myopic contact lens wearers and compares this with patients having gone 
either bilateral Artisan lens implantation or Excimer laser treatments for myopia. 
Furthermore, unique applications of the Artisan lens are considered.
Chapter 1 is a general introduction of the subjects outlined in this thesis. The 
essentials of myopia and hypermetropia are summarized. Studies have found 
that myopia is increasing in alarming rates in Asia. Although inheritance and near 
work have been recognized as substantial risk factors for ametropia, there are no 
known truly effective methods to either prevent or undo myopia or hypermetropia. 
Until recently, one could only correct refractive errors with glasses or contact 
lenses. Although this usually leads to an increased visual acuity, patients still 
have to endure the negative aspects of wearing glasses, such as troublesome 
changes in image size and feelings of self-consciousness. Contact lens wearers 
risk infections and the development of intolerance. These aspects can affect 
Vision-Related Quality of Life in some ametropic individuals. Advances in 
refractive surgery, such as the development of Excimer laser techniques and the 
Artisan phakic IOL, have allowed patients with either myopia or hypermetropia 
to decrease their dependence on spectacles or lenses. The development of 
VR-QOL questionnaires allows us to scrutinize the effects of refractive surgery 
among these patients.
In Chapter 2, we analyze postoperative astigmatism as a factor of incision-
induced corneal astigmatism and axial alignment in a series of 54 eyes implanted 
with the Artisan toric phakic intraocular lens. Also, we calculate both the Safety 
Index and the Efficacy Index of the lens. All axes are labelled preoperatively on 
the cornea with a surgical marker with the use of a Javal keratometer. Mean 
incision-induced corneal astigmatism and mean axial misalignment of the lens 
are found to be nominal (0.75 ± 0.61 D and 0.37° ± 5.34° respectively). Both the 
Safety and Efficacy indexes are securely above 1.0, implying good postoperative 
visual results. We find that the implantation of the toric Artisan lens leads to safe 
and efficacious results, and that axial misalignment of the lens has minimal effects 
on astigmatism. However, the consistent minor effect of the incision-induced 
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astigmatism might warrant a systematic undercorrection of -0.50D to fine tune 
postoperative cylindrical error.
In Chapter 3, we evaluate the results of 26 eyes of 13 patients implanted 
with the Artisan lens for hypermetropia. The study, with a 22-month follow-up, 
demonstrates stable and predictable results, with nearly 91% of eyes achieving 
±1.00D of intended refractive error. However, 2 patients (4 eyes) develop posterior 
synaechiae with pigment deposits. One of these patients eventually undergoes 
bilateral lens removal and clear lens extractions. Furthermore, postoperative 
analysis of the corneal endothelium reveals large, although statistically insignificant 
endothelial cell loss, and a negative correlation between anterior chamber depth 
and the decrease of endothelial cell density.
In Chapter 4, we investigate the postoperative decrease in endothelial cell 
densities (ECD) in 318 myopic eyes that have had Artisan lenses for up to 7 
years. Not only do we find a significant loss of cells after three years, we also find 
a significant negative correlation between the decline in endothelial cell density 
and the depth of the anterior chamber. This loss shows no correlation with any of 
the following: patient age, gender, refractive error or the size of the incision.
The Vision-related Quality of Life (VR-QOL) of myopic contact lens wearers not 
seeking refractive surgery is assessed in Chapter 5. This study, with the use of 
the Dutch translations of the Refractive Vision and Status Profile (RSVP) and 
the National Eye Institute’s Visual-Functioning Questionnaire-25 (NEI-VFQ-25), 
determines that VR-QOL is adversely affected by myopia. The greater the myopia, 
the worse one’s vision-related QOL. This remains independent of both gender and 
age. One year after completion of the initial questionnaire, the subjects complete 
the questionnaires once again, revealing stable results.
In Chapter 6, we study the effects of refractive surgery on VR-QOL. We find 
that nearsighted individuals seeking either bilateral Excimer laser treatments or 
Artisan pIOL implants express lower VR-QOL scores on both the RSVP and the 
NEI-VFQ-25 than their myopic counterparts not seeking treatment. This is mostly 
due to their eagerness to be rid of their contact lenses or glasses. Also, we find 
that patients undergoing uncomplicated refractive surgery experience a significant 
increase in their postoperative VR-QOL scores. Lastly, we observe that both 
Excimer laser and Artisan lens patients score significantly better postoperatively 
on the RSVP than the myopic contact lens wearers. However, with the use of 
the NEI-VFQ-25, only Artisan patients have significantly higher VR-QOL scores 
than contact lens wearers (when correcting for preoperative refractive error). The 
(nearly) emmetropic patients having undergone Excimer laser treatments do not 
score significantly better than myopic contact lens wearers, who remain myopic.
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The implantation of the Artisan lens in the right eye of a four-year old male patient 
with severe unilateral myopia is documented in Chapter 7. Occlusion therapy had 
been severely hampered by poor patient compliance with glasses and contact 
lenses, leading to anisometric amblyopia with a visual acuity varying between 
0.50 and 0.83 in the worse eye and an absence of stereovision. Three years after 
unremarkable surgery, the patient has a best corrected visual acuity of 1.2 in the 
operated eye (versus 1.0 in the other eye) and demonstrates some stereovision. 
Still, there is a demonstrable difference in endothelial cell density between both 
eyes.
In Chapter 8, we study both the objective and subjective results of a unique 
situation where five bilaterally myopic patients (three of which presbyopic) undergo 
a cataract extraction in one eye and an Artisan lens implantation in the other eye 
(to correct the resulting anisometropia). Patients show excellent refractive results 
bilaterally, four out of five being within 1.00 D of emmetropia in the pseudophakic 
eye and all five being within 1.00 D of emmetropia in the phakic Artisan eye. The 
patients are also requested to complete two RSVP questionnaires simultaneously, 
one for each eye. The results of the RSVP demonstrate very similar results for 
both eyes, however there is a significant preference to read with the eye implanted 
with the Artisan lens.
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Samenvatting
De Artisan lens is een intra-oculaire lens (IOL) die in de voorste oogkamer 
geïmplanteerd kan worden. De Artisan lens corrigeert bij- en verziendheid en/of 
astigmatisme, zonder dat de natuurlijke lens van het oog verwijderd hoeft te worden. 
Deze lens kan een ideale optie zijn voor ogen die niet geschikt zijn voor andere 
methoden van refractiechirurgie, of voor patiënten die liever geen irreversibele 
operatie willen ondergaan. Dit proefschrift onderzoekt de visuele resultaten van 
de Artisan lens in hypermetrope en astigmate ogen en het effect van de lens 
op het cornea endotheel. Ook wordt de visueel gerelateerde kwaliteit van leven 
(Vision-Related Quality of Life ofwel VR-QOL) van myope contactlensdragers 
uitgezocht en vergeleken met de VR-QOL van patiënten die bilaterale Artisan lens 
implantaties of excimerlaser behandelingen voor myopie ondergaan. Bovendien 
worden unieke toepassingen van de Artisan lens bekeken.
Hoofdstuk 1 is een algemene introductie tot de onderwerpen die in dit proefschrift 
worden besproken. De hoofdzaken van myopie en hypermetropie zijn samengevat. 
Uit verschillende studies blijkt dat de prevalentie van myopie in Azië in zorgbarende 
aantallen toeneemt. Genetische aanleg en omgevingsfactoren zijn belangrijke 
risicofactoren voor het ontwikkelen van een refractieafwijking. Desondanks zijn 
er geen voldoende effectieve mogelijkheden bekend om invloed uit te oefenen op 
de ontwikkeling of toename van een myopie of hypermetropie. Tot voor kort waren 
een bril of contactlenzen de enige manier om refractieafwijkingen te corrigeren. 
Al leiden deze tot een visusverbetering, patiënten moeten alsnog de ongunstige 
aspecten hiervan verdragen, zoals vervelende veranderingen in beeldgrootte en 
een negatief zelfbeeld. Contactlensdragers riskeren infecties en het ontwikkelen 
van contactlensintolerantie. Dit kan bij sommige mensen de VR-QOL negatief 
beïnvloeden. De opmars van de refractiechirurgie, zoals de ontwikkeling van de 
excimerlaser en van de Artisan phake IOL, leidt tot minder afhankelijkheid van bril 
en/of contactlenzen bij patiënten met myopie of hypermetropie. De ontwikkeling 
van de VR-QOL vragenlijsten laat ons de effecten van refractiechirurgie op de 
kwaliteit van leven bij deze patiënten onderzoeken.
In Hoofdstuk 2 onderzoeken wij in een reeks van 54 ogen het postoperatieve 
astigmatisme veroorzaakt door geïnduceerd astigmatisme door de (wond-)
incisie en de axiale positie van de Artisan torische phake intraoculaire lens. 
Ook berekenen wij de Safety- en Efficacy Index. Preoperatief zijn alle assen 
met een chirurgische marker op de cornea getekend met behulp van de Javal 
keratometer. Het gemiddeld “chirurgisch geïnduceerd” corneaal astigmatisme en 
de gemiddelde axiale afwijking van de lens zijn nominaal (respectievelijk 0.75 ± 
0.61 D en 0.37° ± 5.34°). Zowel de Safety Index als de Efficacy Index zijn meer 
dan 1.0, hetgeen een goede postoperatieve visuele resultaten impliceert. Wij 
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vinden dat de implantatie van de torische Artisan lens tot een veilige en effectieve 
uitkomst leidt, en dat de axiale afwijking van de lens een zeer gering effect 
op astigmatisme heeft. Echter het minimale, maar altijd aanwezige effect van 
astigmatisme geïnduceerd door de incisie zou een systematische ondercorrectie 
van -0.50 D kunnen rechtvaardigen om postoperatieve cilindrische afwijkingen te 
kunnen verminderen.
In Hoofdstuk 3 worden de resultaten de Artisan hypermetrope lens geëvalueerd 
in 26 ogen van 13 patiënten. Deze studie, met een follow-up van 22 maanden, 
toont stabiele en voorspelbare resultaten, waarbij bijna 91% van de ogen binnen 
1.00 D van de voorgenomen refractieafwijking uitkomen. Toch ontwikkelen 2 
patiënten (4 ogen) synechiae posteriores met pigmentdeposities. Bij één van 
deze patiënten zijn beide Artisan lenzen verwijderd en is er een bilaterale heldere 
lens extractie (een cataractextractie bij een heldere lens) verricht. Uit deze studie 
blijkt dat er een groot, echter statistisch niet significant endotheelcelverlies is en 
dat er bovendien een negatieve correlatie bestaat tussen de voorste oogkamer 
diepte en de daling van de endotheelcel dichtheid.
In Hoofdstuk 4 onderzoeken wij de daling van de endotheelcel dichtheid in 318 
myope Artisan lens geïmplanteerde ogen tot 7 jaar postoperatief. Wij vinden 
niet alleen een significant verlies van endotheelcellen na drie jaar maar ook een 
significante negatieve correlatie tussen de daling in endotheelcel dichtheid en 
de diepte van de voorste oogkamer. Dit verlies toont geen correlatie met zowel 
leeftijd als geslacht, refractieafwijking van het oog of incisiegrootte.
In Hoofdstuk 5 wordt de visueel gerelateerde kwaliteit van leven van bijziende 
contactlensdragers die geen refractiechirurgie willen ondergaan beoordeeld. 
Deze studie, waarbij de Nederlandse vertalingen van de Refractive Status and 
Vision Profile (RSVP) en de Visual Functioning Questionnaire van de National Eye 
Institute (NEI-VFQ-25) worden gebruikt, laat zien dat de VR-QOL ongunstig door 
myopie wordt beïnvloed. Hoe groter de myopie, hoe slechter de VR-QOL; dit is 
onafhankelijk van zowel geslacht als leeftijd. Een jaar na initiële voltooiing van de 
vragenlijsten, worden de vragenlijsten opnieuw ingevuld. Dit laat onveranderde 
resultaten zien.
Hoofdstuk 6 beschrijft de gevolgen van refractiechirurgie voor de VR-QOL. Uit 
deze studie blijkt dat myope individuen die bilateraal excimer laserbehandelingen 
of Artisan lens implantaties willen ondergaan slechter scoren dan hun bijziende 
tegenhangers die niet geopereerd willen worden op zowel de RSVP als de 
NEI-VFQ-25. Dit is met name toe te schrijven aan lage scores vanwege het feit 
dat ze graag van hun contactlenzen of bril af willen zijn. Na ongecompliceerde 
refractiechirurgie zien wij een significante toename in de VR-QOL scores. Ten 
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slotte vinden wij dat zowel excimerlaser als Artisan lens patiënten beduidend beter 
postoperatief scoren op de RSVP dan de myope contactlensdragers. Echter bij 
de NEI-VFQ-25 halen slechts de Artisan lens patiënten significant hogere scores 
dan de contactlensdragers (wanneer er gecorrigeerd wordt voor de preoperatieve 
refractieafwijking). De (bijna) emmetrope excimerlaserpatiënten hebben geen 
significant hogere scores op de NEI-VFQ-25 dan de contactlensdragers, die 
overigens nog steeds myoop zijn.
Hoofdstuk 7 documenteert de implantatie van de Artisan lens in het rechter oog 
van een vier jaar oud patiëntje met een ernstige unilaterale myopie, resulterend 
in een anisometropie amblyopie. Door slecht gebruik van de bril en contactlens 
wordt de occlusietherapie sterk belemmerd, met een wisselende visus tussen 
0.50 en 0.83 in het slechtste oog. Tevens is er geen dieptezien. Drie jaar na 
de ongecompliceerde chirurgie, heeft het patiëntje een visus van 1.2 in het 
geopereerde oog (tegenover 1.0 in het linkeroog) en er is grof dieptezien 
aanwezig.
In Hoofdstuk 8 worden zowel de objectieve als subjectieve resultaten bestudeerd 
van een unieke situatie waarbij vijf myope patiënten (drie hiervan presbyoop) 
een cataractextractie ondergaan in één oog en een Artisan lens implantatie in 
het andere oog (om het resulterende anisometropie te corrigeren). Postoperatief 
zijn vier van de vijf pseudofake ogen binnen 1.00 D van emmetropie en alle vijf 
Artisan lenzen geïmplanteerde ogen binnen 1.00 D van emmetropie. De patiënten 
worden verzocht om twee RSVP-vragenlijsten simultaan in te vullen, één voor elk 
oog. De RSVP toont zeer gelijkaardige resultaten voor beide ogen, echter met 
een significante voorkeur om te lezen met het oog met de Artisan lens.
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Naam:   
Registratie nummer:    
Pre-interventie KvL:   
Post-interventie KvL:  
     Datum         Score 
  
Dit is een vragenlijst met uitspraken over problemen die met uw gezichtsvermogen te 
maken hebben, of over gevoelens die u over uw gezichtsvermogen heeft. 
Als u een bril of contactlenzen heeft, ga er dan bij de beantwoording van de vragen van 
uit dat u deze draagt. 
 
 
INSTRUCTIES: 
 
 
1. In het algemeen willen we dat mensen deze vragenlijst zelf proberen in te vullen. Als 
u vindt dat u hulp nodig heeft, aarzel dan niet om het de projectmedewerkers te 
vragen, ze helpen u graag. 
2. Beantwoord alstublieft alle vragen, tenzij u verzocht wordt vragen over te slaan 
omdat ze niet van toepassing zijn. 
3. Beantwoord de vragen door het juiste cijfer te omcirkelen.  
4. Als u niet zeker weet hoe een vraag te beantwoorden, geef dan het best mogelijke 
antwoord en maak een aantekening in de linker kantlijn. 
5. Als u per ongeluk de verkeerde mogelijkheid omcirkeld heeft, dan zet u door deze 
cirkel een kruis en omcirkelt u het antwoord dat volgens u het juiste is.  
6. Vul de vragenlijst in zonder uw antwoorden met uw vrienden of familie te bespreken. 
7. De vragen hebben betrekking op uw situatie gedurende de afgelopen maand. 
8. Er is een versie met grote letters voor het geval uw gezichtsvermogen tekort schiet 
om de lijst in te kunnen vullen. 
9. Als u nog vragen heeft kunt u terecht bij leden van de staf van het project, zij zullen 
u graag helpen. 
 
VERKLARING VAN VERTROUWELIJKHEID: 
 
Alle informatie die identificatie mogelijk maakt van enig persoon die deze vragenlijst 
heeft ingevuld, zal als strikt vertrouwelijk worden beschouwd. Deze informatie zal 
uitsluitend worden gebruikt voor het doel van dit onderzoek, en zal niet worden onthuld 
of vrijgegeven voor enig ander doel, zonder voorafgaande toestemming, geopenbaard 
of gepubliceerd worden, uitgezonderd als vereist bij de wet. 
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Visual Functioning Questionnaire - 25 
 
 
 
 
 
DEEL 1   –   ALGEMENE GEZONDHEID EN GEZICHTSVERMOGEN 
 
 
 
1. Hoe zou u uw algehele gezondheidstoestand omschrijven: 
 
(omcirkel één cijfer) 
 
Uitstekend .......................1 
Zeer goed ........................2 
Goed ................................3 
Redelijk............................4 
Slecht...............................5 
 
 
 
2. Zou u op dit moment zeggen dat uw gezichtsvermogen met beide ogen 
 samen (met bril of contactlenzen, als u deze draagt), uitstekend, goed, 
 redelijk, slecht, zeer slecht is, of bent u volledig blind? 
 
(omcirkel één cijfer) 
 
Uitstekend .......................1 
Goed ................................2 
Redelijk............................3 
Slecht...............................4 
Zeer slecht.......................5 
Volledig blind ..................6 
 
 
 
 -2- versie 2001 
© R 1996 
 
3. Hoe vaak maakt u zich zorgen over uw gezichtsvermogen? 
 
(omcirkel één cijfer) 
 
Nooit…………………………….. 1 
Zelden…………………………... 2 
Soms……………………………. 3 
Vaak…………………………….. 4 
Altijd…………………………….. 5 
 
 
 
4. Hoeveel pijn of ongemak heeft u in en rond uw ogen gehad  (bijvoorbeeld 
 branderigheid, jeuk of pijn)? 
(omcirkel één cijfer) 
 
Geen………………………….…. 1 
Licht…………………………….. 2 
Matig……………………………. 3 
Ernstig………………………….. 4 
Heel ernstig……………………. 5 
 
 
DEEL 2   –   MOEITE MET HET UITVOEREN VAN ACTIVITEITEN 
 
 
De volgende vragen gaan over de moeite die u misschien met sommige 
activiteiten heeft, met bril op of contactlenzen in, mocht u die voor deze activiteit 
nodig hebben. 
 
 
5. Hoeveel moeite heeft u om normale krantendruk te lezen? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
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6.  Hoeveel moeite heeft u met werkzaamheden of hobby’s, waarbij u goed 
 dichtbij moet kunnen zien, zoals koken, naaien, dingen in huis repareren, of 
 bij het gebruik van handgereedschap? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
7. Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, met het vinden van 
 iets op een volle plank? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
 
8.    Hoeveel moeite heeft u met het lezen van straatnaamborden of de namen 
 van winkels? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
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9.     Hoeveel moeite kost het u, vanwege uw gezichtsvermogen, om een afstapje, 
     een trap of een stoeprand af te stappen bij slechte verlichting of ’s nachts? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
10.     Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, om dingen opzij op 
          te merken terwijl u er langs loopt? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
11.      Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, om te zien hoe 
          mensen reageren op wat u zegt? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 -5- versie 2001 
© R 1996 
12.    Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, met het uitzoeken 
        en combineren van uw eigen kleding? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
13.  Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, om bij mensen op 
       visite te gaan, op feesten of in restaurants? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
14.     Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, met het uitgaan om  
          bioscoopfilms, theater of sportevenementen te zien? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
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15. Rijdt u momenteel auto, tenminste af en toe? 
 (omcirkel één cijfer) 
 
 
 Ja………………………………………….….…….……..1  
                                 Ga naar vraag 15c 
 
  
 Nee………………………………………..…………..…...2 
 
 
 
15a. Indien nee, heeft u nooit auto gereden of heeft u het autorijden 
   opgegeven? 
 (omcirkel één cijfer) 
   
 Ik heb nooit auto gereden……….……...………...…1  
                                 Ga naar vraag 17 
 
  
 Ik heb het autorijden opgegeven……………...…...2 
 
 
15b. ALS U HET AUTORIJDEN HEEFT OPGEGEVEN: Was dat 
voornamelijk vanwege uw gezichtsvermogen, voornamelijk om een 
andere reden, of vanwege zowel uw gezichtsvermogen als om een 
andere reden? 
 (omcirkel één cijfer) 
 
    Voornamelijk mijn gezichtsvermogen………………………...…..1  
                                     Ga naar vraag 17 
 
 
    Voornamelijk om andere redenen...…………………………….….2  
                                     Ga naar vraag 17 
 
    
    Zowel mijn gezichtsvermogen als om andere redenen…..……3 
                                        Ga naar vraag 17 
 
 
15c. ALS U MOMENTEEL AUTORIJDT,  hoeveel moeite heeft u met 
autorijden overdag in een bekende omgeving? 
(omcirkel één cijfer) 
 
    Geen enkele moeite…………………………………………….……. 1 
    Een beetje moeite……………………………………………..……... 2 
    Matige moeite…………………………………………………..…….. 3 
    Enorme moeite…………………………………………………..…… 4 
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16. Hoeveel moeite heeft u om ’s nachts auto te rijden? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
16a. Hoeveel moeite heeft u met het rijden onder moeilijke omstandigheden, 
zoals bij slecht weer, tijdens het spitsuur, op de snelweg of in 
stadsverkeer? 
 
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
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DEEL 3   –   OMGAAN MET PROBLEMEN MET HET ZIEN 
 
 
 
De volgende vragen gaan over hoe de dingen die u doet, beïnvloed worden door 
uw gezichtsvermogen. Omcirkel bij elke vraag het nummer om aan te geven of de 
uitspraak voor u altijd, meestal, soms, zelden of nooit geldt. 
 
      (omcirkel één cijfer op elke regel) 
 
  Altijd Meestal Soms Zelden Nooit 
       
17. Krijgt u minder voor elkaar, vanwege 
uw gezichtsvermogen, dan u zou 
willen? 
 
 
1 2 3 4 5 
18. Bent u, vanwege uw gezichts-
vermogen, beperkt in hoe lang u 
kunt werken of andere activiteiten 
kunt volhouden?  
 
 
1 2 3 4 5 
19. In hoeverre weerhoudt pijn of 
ongemak in of rond de ogen, 
bijvoorbeeld branden, jeuken of pijn, 
u ervan om de dingen te doen die u 
zou willen doen?  
1 2 3 4 5 
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Omcirkel na elk van de volgende uitspraken het voor u meest passende antwoord 
om aan te geven dat de uitspraak voor u helemaal juist is, over het algemeen juist 
is, over het algemeen onjuist is, of helemaal onjuist is, of dat u het niet zeker 
weet. 
(omcirkel één cijfer op elke regel) 
 
 
  Helemaal 
juist 
Over het 
algemeen 
juist 
Weet 
het niet 
zeker 
Over het 
algemeen 
onjuist  
Helemaal 
onjuist 
       
20. Ik blijf vanwege mijn 
gezichtsvermogen 
meestal thuis 
 
 
1 2 3 4 5 
21. Ik voel me vaak 
gefrustreerd vanwege 
mijn gezichtsvermogen 
 
 
1 2 3 4 5 
22. Ik heb veel minder 
controle over wat ik doe, 
vanwege mijn gezichts-
vermogen  
1 2 3 4 5 
       
23. Vanwege mijn gezichts-
vermogen moet ik teveel 
vertrouwen over wat 
andere mensen me 
vertellen 
1 2 3 4 5 
       
24. Ik heb veel hulp van 
anderen nodig vanwege 
mijn gezichtsvermogen 
1 2 3 4 5 
       
25. Ik maak me zorgen dat 
ik dingen doe, vanwege 
mijn gezichtsvermogen, 
die mezelf of anderen in 
verlegenheid brengen 
1 2 3 4 5 
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Bijlage optionele vragen 
 
SUBSCHAAL: ALGEMENE GEZONDHEID 
 
A1. Hoe zou u uw gezondheid beoordelen, op een schaal van 0 tot 10, waarbij 0 
         zo slecht als dood is en 10 de best mogelijke gezondheid? 
 
(omcirkel één cijfer op elke regel) 
  
 0 1 2 3 4 5 6 7 8 9 10 
 
Slechtste 
          
Beste 
 
 
SUBSCHAAL: ALGEMEEN GEZICHTSVERMOGEN 
 
A2. Hoe zou u nu uw gezichtsvermogen beoordelen (met bril op of contactlenzen  
 in, als u deze draagt) op een schaal van 0 tot 10 waarbij 0 zo slecht is als  
 blindheid en 10 het best mogelijke gezichtsvermogen? 
 
(omcirkel één cijfer op elke regel) 
  
0 1 2 3 4 5 6 7 8 9 10 
 
Slechtste 
          
Beste 
 
 
SUBSCHAAL: DICHTBIJ ZIEN 
 
A3. Hoeveel moeite heeft u om, met bril op, kleine lettertjes in een telefoonboek, 
 op een medicijnflesje of in officiële stukken te lezen? 
 
 (omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
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A4. Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, om te bepalen of  
         rekeningen die u ontvangt kloppen? 
  
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
A5. Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, met dingen zoals 
         scheren, uw haar in model brengen of make-up op doen? 
 (omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
 
SUBSCHAAL: VERAF ZIEN 
 
A6. Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, om bekenden aan 
         de andere kant van de kamer te herkennen? 
  
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
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A7. Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, om actief sport te  
         beoefenen of aan buitenactiviteiten deel te nemen waar u van houdt (zoals  
         golf, bowlen, wandelen of fietsen)? 
 (omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
 
A8. Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, met het zien en  
         genieten van programma’s op de TV? 
  
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
 
SUBSCHAAL: SOCIAAL FUNCTIONEREN 
 
 
A9. Hoeveel moeite heeft u, vanwege uw gezichtsvermogen, met het ontvangen,  
         als gastheer of gastvrouw, van familie en vrienden bij u thuis? 
  
(omcirkel één cijfer) 
 
Geen enkele moeite…………………………………………………….….. 1 
Een beetje moeite……………………………………………………..…… 2 
Matige moeite…………………………………………………………..…. . 3 
Enorme moeite…………………………………………………………..…. 4 
Hiermee gestopt vanwege het slechte gezichtsvermogen……..…... 5 
Hiermee gestopt om andere redenen, of op u niet van toepassing. 6 
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SUBSCHAAL: AUTORIJDEN 
 
A10. (Deze vraag over het autorijden onder moeilijke omstandigheden is 
verplaatst en heeft u reeds beantwoord als vraag 16a.) 
 
 
 
SUBSCHAAL: ROL BEPERKINGEN 
 
A11. De volgende vragen gaan over dingen die u misschien doet vanwege uw  
 gezichtsvermogen. Omcirkel bij elke vraag het nummer om aan te geven of  
 de uitspraak voor u altijd, meestal, soms, zelden of nooit geldt. 
 
 
                  (omcirkel één cijfer) 
 
  Altijd Meestal Soms Zelden Nooit 
       
a Krijgt u meer hulp van anderen, 
vanwege uw gezichtsvermogen? 
 
 
1 2 3 4 5 
b Bent u beperkt, vanwege uw 
gezichtsvermogen, in het soort 
dingen die u kunt doen? 
 
 
1 2 3 4 5 
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SUBSCHAAL: WELZIJN (#A12) en AFHANKELIJKHEID (#A13) 
 
 
De volgende vragen gaan over hoe u met uw gezichtsvermogen omgaat. Omcirkel 
na elk van de volgende uitspraken het voor u meest passende antwoord om aan 
te geven dat de uitspraak helemaal juist is, over het algemeen juist is, over het 
algemeen onjuist is, of helemaal onjuist is, of dat u het niet zeker weet. 
 
                  (omcirkel één cijfer) 
 
  Helemaal 
juist 
Over het 
algemeen 
juist 
Weet 
het niet 
zeker 
Over het 
algemeen 
onjuist 
Helemaal 
onjuist 
       
A12 Ik ben vaak prikkelbaar 
vanwege mijn 
gezichtsvermogen 
 
 
1 2 3 4 5 
A13 Ik ga niet buiten mijn 
huis vanwege mijn 
gezichtsvermogen 
 
 
 
 
 
1 2 3 4 5 
 
 
 
 
 
Dit is het einde van de vragenlijst. 
Hartelijk dank voor uw hulp. 
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REFRACTIVE STATUS AND VISION PROFILE 
 
ACHTERGRONDINFORMATIE 
 
Patiëntinformatie 
 
1. Leeftijd    
      jaar 
 
2. Geslacht: 
Vrouw           (     1) 
Man           (     2) 
 
Bril- en Contactlensgebruik 
 
3. Ik droeg in de afgelopen maand bij het kijken in de 
verte: 
 
a. Alleen een bril          (     1) 
b. Voornamelijk een bril, soms contactlenzen
           (     2) 
c. Ongeveer even vaak een bril als contactlenzen
           (     3) 
d. Voornamelijk contactlenzen, soms een bril
           (     4) 
e. Alleen contactlenzen         (     5) 
 
4. Droeg u in de afgelopen maand een aparte bril (of 
bifocale bril) om dichtbij te kunnen zien? 
( ja   1)         ( nee2) 
 
5. Indien u in de afgelopen maand contactlenzen droeg, 
waren dat dan: 
 
a. Harde zuurstofdoorlaatbare         (     1) 
b. Zachte lenzen          (     2) 
c. Wegwerplenzen         (     3) 
d. Geen lenzen in de afgelopen maand gedragen  
 (    4) 
 
6. Indien u in de afgelopen maand contactlenzen droeg, 
droeg u ze ooit de hele nacht? 
( ja   1)         ( nee2) 
 
7. Zo ja (bij vraag 6), hoeveel nachten heeft u ze 
gewoonlijk ingehouden voordat u ze uitdeed? 
 
 
 
 
 
 
 
 
 
 
Wij zijn geïnteresseerd in uw gezichtsvermogen  
gedurende de afgelopen maand. 
 
Beantwoordt alstublieft de volgende drie vragen 
door een getal tussen 0 en 10 op te schrijven, 
waarbij 0 volledig blind betekent en 10 een perfect 
gezichtsvermogen: 
 
8. Schat uw gezichtsvermogen met bril, gedurende 
de afgelopen maand: 
 
(geen bril in de afgelopen maand gedragen) 
 
9. Schat uw gezichtsvermogen met contactlenzen, 
gedurende de afgelopen maand: 
 
(geen contactlenzen in de afgelopen maand 
gedragen) 
 
10. Schat uw gezichtsvermogen zonder bril of 
contactlenzen, gedurende de afgelopen maand: 
 
 
11. Hoe tevreden was u, gedurende de afgelopen 
maand, met uw vermogen om te kunnen lezen en 
om werk, dat dichtbij zien vereist, te kunnen 
verrichten (met de bril of contactlenzen die u 
gewoonlijk gebruikt bij het lezen, indien u dat 
deed) (slechts één aankruisen):  
 
Heel ontevreden      (     1) 
Ontevreden       (     2) 
Noch tevreden, noch ontevreden     (     3) 
Tevreden       (     4) 
Heel tevreden       (     5) 
Niet van toepassing      (     6) 
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12. Hoe tevreden was u, gedurende de afgelopen 
maand, met uw huidige gezichtsvermogen met bril 
(slechts één aankruisen): 
 
Heel ontevreden       (     1) 
Ontevreden       (     2) 
Noch tevreden, noch ontevreden     (     3) 
Tevreden        (     4) 
Heel tevreden       (     5) 
Niet van toepassing (geen bril gedragen gedurende 
de afgelopen maand)      (     6) 
 
 
13. Hoe tevreden was u, gedurende de afgelopen 
maand, met uw huidige gezichtsvermogen met 
contactlenzen (slechts één aankruisen): 
 
Heel ontevreden       (     1) 
Ontevreden       (     2) 
Noch tevreden, noch ontevreden     (     3) 
Tevreden        (     4) 
Heel tevreden       (     5) 
Niet van toepassing (geen contactlenzen gedragen 
gedurende de afgelopen maand)     (     6) 
 
 
14. Hoe tevreden was u, gedurende de afgelopen 
maand, met uw huidige gezichtsvermogen 
ZONDER bril of contactlenzen (slechts één 
aankruisen): 
 
Heel ontevreden       (     1) 
Ontevreden       (     2) 
Noch tevreden, noch ontevreden     (     3) 
Tevreden        (     4) 
Heel tevreden       (     5) 
 
 
15. Zou u uw gezondheid gedurende de afgelopen 
maand in het algemeen omschrijven als (slechts één 
aankruisen): 
 
Uitstekend        (     1) 
Heel goed        (     2) 
Goed        (     3) 
Matig        (     4) 
Slecht        (     5) 
 
 
 
 
 
 
 
 
16. Hoe bezorgd bent u geweest over uw gezondheid 
gedurende de afgelopen maand (slechts één 
aankruisen): 
 
0  (helemaal niet bezorgd)      (     1) 
1        (     2) 
2        (     3) 
3        (     4) 
4        (     5) 
5        (     6) 
6        (     7) 
7        (     8) 
8        (     9) 
9        (    10) 
10 (heel bezorgd)       (    11) 
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REFRACTIVE STATUS AND VISION PROFILE 
 
VRAGENLIJST 
 
 
Gezichtsvermogen  
 
Beantwoord de vragen alstublieft voor zover ze op u van 
toepassing zijn over de afgelopen maand. 
 
17. Ik maak me zorgen over mijn gezichtsvermogen  
       (slechts één aankruisen): 
 
Nooit        (     1) 
Zelden        (     2) 
Soms        (     3) 
Vaak        (     4) 
Altijd        (     5) 
 
 
 
18. Mijn gezichtsvermogen is een zorg in mijn leven 
(slechts één aankruisen): 
 
Nooit        (     1) 
Zelden        (     2) 
Soms        (     3) 
Vaak        (     4) 
Altijd        (     5) 
 
 
 
19. Mijn gezichtsvermogen remt mij in mijn doen en 
laten (slechts één aankruisen): 
 
Nooit        (     1) 
Zelden        (     2) 
Soms        (     3) 
Vaak        (     4) 
Altijd        (     5) 
 
 
 
20. Ik ben gefrustreerd over mijn gezichtsvermogen 
(slechts één aankruisen): 
 
Nooit        (     1) 
Zelden        (     2) 
Soms        (     3) 
Vaak        (     4) 
Altijd        (     5) 
 
 
 
 
21. Mijn gezichtsvermogen maakt mij minder 
zelfstandig (slechts één aankruisen): 
 
Nooit        (     1) 
Zelden        (     2) 
Soms        (     3) 
Vaak        (     4) 
Altijd        (     5) 
 
 
 
22. Vanwege mijn gezichtsvermogen zijn er dingen die 
ik bang ben om te doen (slechts één aankruisen): 
 
Nooit        (     1) 
Zelden        (     2) 
Soms        (     3) 
Vaak        (     4) 
Altijd        (     5) 
 
 
 
23. Ik zou een gezichtsvermogen kunnen accepteren dat 
niet helemaal perfect is als ik geen bril of 
contactlenzen meer nodig zou hebben (slechts één 
aankruisen): 
 
Sterk mee oneens       (     1) 
Mee oneens        (     2) 
Noch mee eens, noch mee oneens     (     3) 
Mee eens        (     4) 
Sterk mee eens       (     5) 
Geen bril of contactlenzen nodig om het best 
mogelijke gezichtsvermogen te halen    (     6) 
 
 
 
24. Zolang ik goed genoeg kan zien om auto te rijden 
zonder bril of contactlenzen, zou ik het niet erg 
vinden om een gezichtsvermogen te hebben dat niet 
helemaal perfect is (slechts één aankruisen): 
 
Sterk mee oneens       (     1) 
Mee oneens        (     2) 
Noch mee eens, noch mee oneens     (     3) 
Mee eens        (     4) 
Sterk mee eens       (     5) 
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Wij willen graag weten of uw gezichtsvermogen u enige moeite bezorgde met enkele gewone bezigheden gedurende 
de afgelopen maand. 
 
De volgende vragen gaan over moeite die u mogelijk had bij een activiteit, met bril, met contactlenzen of geen van 
beide (noch bril, noch contactlenzen). 
 
Geeft u alstublieft antwoord voor alle drie de vormen van correctie (er is een keuzemogelijkheid “niet van toepassing”). 
 
De antwoordkeuzen zijn:  0 Niet van toepassing (heb deze vorm van correctie in de afgelopen maand  
    niet gebruikt) 
 
1 Geen enkele moeite 
2 Een beetje moeite 
3 Matige moeite 
4 Enorme moeite 
5 Zoveel moeite dat ik deze activiteit niet heb gedaan met deze vorm van 
correctie  
 
6 Nooit deze activiteit gedaan om andere redenen (niet in verband met 
gezichtsvermogen) 
 
 
Hoeveel moeite heeft u gehad, gedurende de afgelopen maand, met elk van de volgende activiteiten, 
gebruikmakend van de onderstaande vormen van correctie? 
 
Activiteit        Met Bril               Met Contactlenzen   Zonder Correctie 
                                                        (omcirkel een cijfer)              (omcirkel een cijfer)              (omcirkel een cijfer) 
 
25. TV of films kijken                     0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
26. Buitenspelen of -werken            0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
27. Zorgen voor of spelen             0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
met kinderen 
28. Uw wekker zien             0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
29. Helder zien als u wakker             0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
 wordt 
30. Een klok aan de muur            0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
zien 
31. Uw werk doen             0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
32. Aan sport of recreatie            0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
 doen 
33. Zwemmen             0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
34. Uw sociaal leven             0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
35. Lezen en werk dat             0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
dichtbij zien vereist 
36. `s Nachts autorijden            0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
37. Autorijden als het regent            0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
38. Autorijden als er              0    1  2  3  4  5    6   0    1  2  3  4  5    6    0    1  2  3  4  5    6 
schitteringen door  
 koplampen van  
 tegenliggers optreden 
 
Refractive Status and Vision Profile – NL Vertaling 
 
© 1998, The Johns Hopkins University  
All rights reserved. 
 
5
Wij willen graag weten of u bepaalde problemen ervoer met uw ogen of gezichtsvermogen gedurende de afgelopen 
maand. 
 
De volgende vragen gaan over elk probleem met bril, met contactlenzen of met geen van beide (noch bril, noch 
contactlenzen). 
 
Geef alstublieft antwoord voor alle drie de vormen van correctie (er is een keuzemogelijkheid “niet van toepassing”). 
 
De antwoordkeuzen zijn:  0 Niet van toepassing (heb deze vorm van correctie in de afgelopen maand  
    niet gebruikt) 
 
1 Geen enkele last 
2 Een beetje last 
3 Matige last 
4 Enorme last 
5 Zoveel last dat ik deze vorm van correctie niet gebruik 
 
 
Hoeveel last heeft u gehad, gedurende de afgelopen maand, van de volgende dingen, bij het gebruiken 
van de bril, contactlenzen of geen van beide? 
 
           Probleem     Met Bril  Met Contactlenzen  Zonder Correctie 
       (omcirkel een cijfer)            (omcirkel een cijfer)             (omcirkel een cijfer) 
 
39. Het geïrriteerd aanvoelen             0    1  2  3  4  5       0    1  2  3  4  5        0    1  2  3  4  5   
van uw ogen  
40. Tocht (van de verwarming            0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
of airconditioning) die in  
uw ogen blaast 
41. Het overgevoelig zijn van             0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
uw ogen voor licht 
42. Pijn in uw ogen             0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
43. Veranderingen van uw              0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
gezichtsvermogen in de  
loop van de dag 
44. Mistig of wazig zien              0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
45. Schitteringen              0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
(weerspiegelingen van  
glimmende oppervlakten, 
sneeuw) 
46. Dingen die er met het ene            0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
oog anders uitzien dan met  
het andere 
47. Het zien van kringen rondom           0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
lichten 
48. Zien in schemerlicht              0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
49. Uw dieptezien             0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
50. Dingen lijken vervormd            0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
51. Het schatten van afstand            0    1  2  3  4  5         0    1  2  3  4  5        0    1  2  3  4  5   
bij het op- of afstappen van   
treden (trappen,  
stoepranden) 
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De volgende reeks vragen gaat over problemen die u mogelijk had gedurende de afgelopen maand met bril of 
contactlenzen. 
 
Geef alstublieft antwoord voor elk item (er is een keuzemogelijkheid “niet van toepassing”). 
 
De antwoordkeuzen zijn: 0 Niet van toepassing (heb deze vorm van correctie in de afgelopen maand niet  
   gebruikt) 
 
1 Geen enkele last van dit probleem 
2 Een beetje last van dit probleem 
3 Matige last van dit probleem 
4 Enorme last van dit probleem 
5 Zoveel last van dit probleem dat ik deze vorm van correctie gedurende de 
afgelopen maand niet heb gebruikt 
 
 
Hoeveel last heeft u gehad van de volgende problemen gedurende de afgelopen maand? 
 
                   (omcirkel een cijfer) 
 
52. Het vies of bekrast worden van uw bril    0    1  2  3  4  5   
53. Het beslagen of nat worden van uw bril    0    1  2  3  4  5   
54. Het uit uw oog springen/vallen van contactlenzen   0    1  2  3  4  5   
55. Het onder uw ooglid vast komen te zitten    0    1  2  3  4  5   
 of in uw oog rondbewegen van contactlenzen 
56. Het gevoel dat u contactlenzen in uw ogen heeft   0    1  2  3  4  5   
57. Het niet kunnen dragen van contactlenzen zo lang  0    1  2  3  4  5   
 als het nodig is 
58. Het kwijtraken van een contactlens    0    1  2  3  4  5   
 
 
 
 
EINDE VAN DE VRAGENLIJST 
 
Dank u voor uw tijd. 
 
Heeft u nog vragen of opmerkingen? 
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Taji and Bhabi, I cannot thank you enough for putting up with me in your home for 
two whole years! You are both such unassuming people, I hope you realize how 
much you mean to us. Taji, I am very lucky to have such a talented researcher in 
the family, thank you for all your time and advice.
To my Parents. Even though you’re so far away, you manage to be an amazing 
support system for both Ollie and I – thank you. Also, thank you so much for 
putting up with me! I really am very fortunate for having such kind, understanding 
and loving parents. You both also helped me a lot by reviewing this manuscript 
all the way from Canada. Without your encouragement and support, I would have 
never ended up where I am. Nup, the eternal party planner - thanks for all your 
ideas surrounding “het promotiefeestje”.
Finally, the love of my life, Oliver. As requested, I shall mention Christmas 2005, 
when you spent the whole day inputting data into that crazy Excel worksheet, so 
that I would have my presentation ready on time! It amazes me, that after fourteen 
years together and all that we’ve been through, you still keep me laughing. 
Throughout everything, you’ve been wonderful, kind, supportive, incredibly
patient and always optimistic. Words are just not enough.


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Ruchi Saxena was born during her parents’ holiday in Lucknow, India on December 
11th, 1972. At the time, her parents were residing in Delft, the Netherlands, where 
her older sister, Nupur, was born 2 years previously. At the age of nine months, 
her family moved to Belgium, and at the age of 5, to Montreal, Quebec, Canada. 
In 1983, the family moved yet again, this time to Oakville, Ontario, Canada. She 
graduated in 1992 from Queen Elizabeth Park School, also in Oakville, with a 
Diploma in French Immersion. In 1996, she graduated from the University of 
Toronto, Toronto, Ontario, Canada, with an Honours Bachelor of Science, majoring 
in Human Biology and Zoology. During her stay at the University, she served as 
President of the New College Residence Council for two years. For her work, she 
received the Katherine Grace Baker Memorial Award in 1995 and the Gordon 
Cressy Student Leadership Award in 1996. After following a course in Vertebrate 
Regeneration and performing microscopic surgery on lizards in her final year, she 
decided that she wanted to pursue a career in Medicine.
After moving to the Netherlands in 1996 and completing a Dutch language course 
in 1997, Ruchi began her Medical Studies at the Erasmus University in Rotterdam. 
In her third year, she followed an elective course on refractive surgery offered 
by Dr. G.P.M. Luyten at the Department of Ophthalmology, Erasmus MC. This 
course further stimulated her interest in the field and she went on to publish two 
articles on refractive surgery, which she had written as her Masters thesis. These 
studies led to her being awarded the Gerrit Jan Mulder Prize in 2003. During her 
Medical Clerkship, she continued to work on her research in refractive surgery. 
This work was in cooperation with Dr. M.A. Landesz and Dr. M.A.H. Luger at 
Vision Clinics in Delft and with Willem Vreugdenhil from Oculenti Contact Lens 
Specialists at the Rotterdam Eye Hospital. She received her Medical Diploma in 
2004 and is currently completing her specialization in Ophthalmology at Erasmus 
MC, under Prof. Dr. G. van Rij. The bulk of her research and writing was done 
during her Medical Clerkship and later, during her specialization.
Unfortunately, Ruchi has inherited the myopia that plagues 11 of the 12 
grandchildren on her father’s side of the family. Sadly, her eyes are not suitable 
for refractive surgery and she has to make do with contact lenses. On April 13th 
2006, Ruchi married Oliver Gnjec. As you can imagine, she kept her own name.
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